carzenide profile

ID Source	ID
PubMed CID	8739
CHEMBL ID	414
CHEBI ID	177418
SCHEMBL ID	312419
MeSH ID	M0042315

Synonym
EU-0033692
4-carboxybenzenesulfonamide 1
aromatic/heteroaromatic sulfonamide 23
chembl414 ,
benzoic acid deriv. 31
bdbm4703
jmc52646 compound 23
jmc522226 compound 22
jmc523116 compound 22
EN300-16248
BB 0237911
CHEBI:177418
4-sulamoylbenzoic acid
nsc683540
MLS000069605
smr000059013
4-carboxybenzenesulfonamide
carzenide ,
nsc22976 ,
nsc-22976
p-sulfamoylbenzoic acid
p-sulfamylbenzoic acid
benzoic acid, p-sulfamoyl-
p-carboxybenzenesulfonamide
138-41-0
p-sulfonamidobenzoic acid
dirnate
benzoic acid, 4-(aminosulfonyl)-
4-sulfamoylbenzoic acid
benzoic acid p-sulfamide
carzenid
DIVK1C_001137
NCI60_001869
brn 1875393
carzenidum [inn-latin]
carzenide [inn]
nsc 22976
carzenida [inn-spanish]
4-sulfamoylbenzoesaeure
einecs 205-327-4
CDS1_000097
4-(aminosulfonyl)benzoic acid
NCGC00013287
OPREA1_448551
4-sulfamoylbenzoic acid, 97%
nsc-683540
NCI22976
MAYBRIDGE1_002385
NCISTRUC2_000413
NCISTRUC1_000566
SR-01000000114-3
NCGC00021607-04
NCGC00021607-03
NCGC00013287-02
AKOS000144547
HMS548E09
4-sulfamolybenzoic acid
para-carboxybenzenesulfonamide
D09322
carzenide (inn)
ucaglbktlxcodc-uhfffaoysa-
inchi=1/c7h7no4s/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4h,(h,9,10)(h2,8,11,12)
STK802346
NCGC00013287-06
HMS3264O07
4-aminosulfonylbenzoic acid
carzenidum
carzenida
30z5hqb5a4 ,
unii-30z5hqb5a4
4-sulfamoyl-benzoic acid
BBL011102
nsc758886
nsc-758886
pharmakon1600-01504505
dtxsid1045089 ,
dtxcid9025089
tox21_110021
cas-138-41-0
HMS2234G21
S4556
CCG-38010
NCGC00013287-07
NCGC00013287-03
NCGC00013287-04
NCGC00013287-05
4-sulfamidobenzoic acid
benzoic acid 4-sulfamide
FT-0619469
4so ,
AM20060310
carzenide [mi]
carzenide [who-dd]
carzenide [mart.]
HMS3369M14
SCHEMBL312419
4-carboxy-benzenesulfonamide
p-aminosulfonyl-benzoic acid
4-carboxyphenylsulfonamide
4-sulphamoyl-benzoic acid
tox21_110021_1
CS-4482
cambridge id 5121815
W-108229
carzenide(4-aminosulfonylbenzoic acid)
p-aminosulfonylbenzoic acid
4-(aminosulfonyl)benzoic acid #
HY-B0989
AB00384334_11
mfcd00007938
F0347-1766
sr-01000000114
SR-01000000114-2
Z53021532
SR-01000000114-4
SBI-0054135.P002
p-carboxybenzene sulfonamide
p-sulfamoyl-benzoic acid
AS-14571
BRD-K09295674-001-08-0
A16430
Q27255987
SB78174

Class	Description
sulfonamide	An amide of a sulfonic acid RS(=O)2NR'2.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Chain A, Beta-lactamase	Escherichia coli K-12	Potency	89.1251	0.0447	17.8581	100.0000	AID485294
GLI family zinc finger 3	Homo sapiens (human)	Potency	23.7101	0.0007	14.5928	83.7951	AID1259369
cytochrome P450 2C19 precursor	Homo sapiens (human)	Potency	7.9433	0.0025	5.8400	31.6228	AID899
chromobox protein homolog 1	Homo sapiens (human)	Potency	89.1251	0.0060	26.1688	89.1251	AID540317
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Carbonic anhydrase	Astrosclera willeyana	Ki	1.2150	0.0320	1.5172	9.6000	AID644379
Carbonic anhydrase	Sulfurihydrogenibium sp. YO3AOP1	Ki	0.0724	0.0045	0.1624	0.8760	AID1268964
Carbonic anhydrase	Stylophora pistillata	Ki	0.4350	0.0000	0.6867	10.0000	AID436565; AID552130
Carbonic anhydrase	Stylophora pistillata	Ki	0.6070	0.0000	0.5071	5.7100	AID552131
Carbonic anhydrase	Helicobacter pylori 26695	Ki	1.0675	0.0200	0.5486	4.3600	AID261581; AID263638
Carbonic anhydrase 12	Homo sapiens (human)	Ki	0.0340	0.0002	1.1043	9.9000	AID238316; AID239126
Carbonic anhydrase 1	Homo sapiens (human)	IC50 (µMol)	120.0000	0.0058	2.1410	7.9000	AID1809103; AID1809971
Carbonic anhydrase 1	Homo sapiens (human)	Ki	10.1830	0.0000	1.3726	10.0000	AID1142833; AID1188134; AID1190063; AID1194024; AID1195369; AID1268962; AID1275913; AID1287517; AID1291357; AID1434427; AID1453412; AID1628036; AID1796552; AID1796855; AID1798769; AID238247; AID238276; AID238753; AID261579; AID263636; AID275807; AID349605; AID367820; AID369271; AID414955; AID427125; AID436563; AID50371; AID552127; AID577526; AID612725; AID644380; AID725955
Carbonic anhydrase 2	Homo sapiens (human)	IC50 (µMol)	10.2933	0.0002	1.1060	8.3000	AID1809104; AID1809972; AID241604
Carbonic anhydrase 2	Homo sapiens (human)	Ki	0.8704	0.0000	0.7236	9.9200	AID1061069; AID1142834; AID1188135; AID1190064; AID1194025; AID1195370; AID1240217; AID1268963; AID1275912; AID1278409; AID1287518; AID1291358; AID1434428; AID1453413; AID1628037; AID1796552; AID1796582; AID1796855; AID1798769; AID238255; AID238300; AID238768; AID256963; AID261580; AID263637; AID275808; AID349606; AID367821; AID369272; AID414956; AID427124; AID436564; AID437749; AID47936; AID48089; AID552128; AID577527; AID612726; AID644381; AID669115; AID725956
Carbonic anhydrase 2	Bos taurus (cattle)	Ki	0.1510	0.0025	1.1325	7.5858	AID257601
Neuraminidase	Influenza A virus (A/tern/Australia/G70C/1975(H11N9))	IC50 (µMol)	2,500.0000	2.5000	2.5000	2.5000	AID1795674
Carbonic anhydrase 3	Homo sapiens (human)	Ki	11.3000	0.0002	2.0102	10.0000	AID301578
5-hydroxytryptamine receptor 2C	Rattus norvegicus (Norway rat)	Ki	0.0400	0.0002	0.6677	10.0000	AID47936
5-hydroxytryptamine receptor 2A	Rattus norvegicus (Norway rat)	Ki	0.0400	0.0001	0.6017	10.0000	AID47936
Carbonic anhydrase 6	Homo sapiens (human)	Ki	1.6396	0.0001	1.4710	9.9200	AID1798769; AID275806; AID369273; AID552129
5-hydroxytryptamine receptor 2B	Rattus norvegicus (Norway rat)	Ki	0.0400	0.0002	0.5909	10.0000	AID47936
Delta-type opioid receptor	Mus musculus (house mouse)	Ki	0.1050	0.0000	0.5393	9.4000	AID1188134; AID1188135
Delta-type opioid receptor	Rattus norvegicus (Norway rat)	Ki	0.0460	0.0000	0.6068	9.2330	AID1188135
Mu-type opioid receptor	Rattus norvegicus (Norway rat)	Ki	0.1640	0.0000	0.3845	8.6000	AID1188134
Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)	IC50 (µMol)	2.6500	0.0200	3.1081	9.4000	AID241574
Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)	Ki	1.7483	0.0000	1.2725	9.9000	AID1796582; AID256964
Carbonic anhydrase 7	Homo sapiens (human)	Ki	0.0520	0.0002	1.3737	9.9000	AID238256
Carbonic anhydrase	Saccharomyces cerevisiae S288C	Ki	14.5000	0.0820	0.5609	8.7000	AID367822
Mu-type opioid receptor	Cavia porcellus (domestic guinea pig)	Ki	0.0460	0.0000	0.2786	9.0000	AID1188135
Beta-carbonic anhydrase 1	Mycobacterium tuberculosis H37Rv	Ki	8.2100	0.0048	3.3841	9.8400	AID1798985; AID349607
Carbonic anhydrase 2	Mycobacterium tuberculosis H37Rv	Ki	39.2000	0.0090	2.2096	9.8400	AID437750
Carbonic anhydrase 9	Homo sapiens (human)	IC50 (µMol)	24.0000	0.0003	0.6302	9.3900	AID1809105; AID1809973
Carbonic anhydrase 9	Homo sapiens (human)	Ki	0.9106	0.0001	0.7874	9.9000	AID1796855; AID1798769; AID238769; AID239102; AID275809; AID369274; AID48296; AID48300
Carbonic anhydrase, alpha family	Hydrogenovibrio crunogenus XCL-2	Ki	0.0852	0.0025	0.3234	1.1000	AID1268965
Carbonic anhydrase	Cryptococcus neoformans var. grubii	Ki	0.4840	0.0100	0.7364	8.3470	AID669116
Carbonic anhydrase	Candida albicans SC5314	Ki	0.7668	0.0105	1.4444	8.3470	AID1799266; AID427122; AID669117
Carbonic anhydrase	Anopheles gambiae (African malaria mosquito)	Ki	0.7030	0.0098	0.5117	4.3600	AID1195371
Delta carbonic anhydrase	Conticribra weissflogii	Ki	0.8710	0.0496	0.9978	9.2000	AID1061066
Carbonic anhydrase	Nakaseomyces glabratus CBS 138	Ki	0.0530	0.0070	1.2174	9.1700	AID744415
Carbonic anhydrase 4	Bos taurus (cattle)	Ki	0.0860	0.0030	0.5934	9.6500	AID48280
Carbonic anhydrase 15	Mus musculus (house mouse)	Ki	3.3957	0.0009	1.8846	10.0000	AID1798769; AID369275
Carbonic anhydrase 14	Homo sapiens (human)	Ki	0.7800	0.0002	1.5099	9.9000	AID239703
Sialidase-3	Homo sapiens (human)	IC50 (µMol)	2,500.0000	2.4000	5.9980	8.1700	AID147479
Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)	Ki	1.4757	0.0000	1.3412	9.9700	AID1796582; AID256965
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Carbonic anhydrase 2	Homo sapiens (human)	Kd	0.8900	0.0000	0.4157	5.5500	AID1307761
Carbonic anhydrase 2	Bos taurus (cattle)	Kd	0.8900	0.8900	3.3850	5.8800	AID1307763
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Carbonic anhydrase	Brucella suis 1330	Kinact	0.3400	0.0170	0.8628	5.8700	AID459696
Carbonic anhydrase 1	Homo sapiens (human)	Kinact	23.0000	0.0100	0.9387	8.6000	AID299242
Carbonic anhydrase 2	Homo sapiens (human)	Kinact	0.1330	0.0030	0.7946	10.0000	AID299243
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
estrous cycle	Carbonic anhydrase 12	Homo sapiens (human)
chloride ion homeostasis	Carbonic anhydrase 12	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 12	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 1	Homo sapiens (human)
morphogenesis of an epithelium	Carbonic anhydrase 2	Homo sapiens (human)
positive regulation of synaptic transmission, GABAergic	Carbonic anhydrase 2	Homo sapiens (human)
positive regulation of cellular pH reduction	Carbonic anhydrase 2	Homo sapiens (human)
angiotensin-activated signaling pathway	Carbonic anhydrase 2	Homo sapiens (human)
regulation of monoatomic anion transport	Carbonic anhydrase 2	Homo sapiens (human)
secretion	Carbonic anhydrase 2	Homo sapiens (human)
regulation of intracellular pH	Carbonic anhydrase 2	Homo sapiens (human)
neuron cellular homeostasis	Carbonic anhydrase 2	Homo sapiens (human)
positive regulation of dipeptide transmembrane transport	Carbonic anhydrase 2	Homo sapiens (human)
regulation of chloride transport	Carbonic anhydrase 2	Homo sapiens (human)
carbon dioxide transport	Carbonic anhydrase 2	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 2	Homo sapiens (human)
angiotensin-activated signaling pathway	Carbonic anhydrase 2	Bos taurus (cattle)
regulation of monoatomic anion transport	Carbonic anhydrase 2	Bos taurus (cattle)
regulation of intracellular pH	Carbonic anhydrase 2	Bos taurus (cattle)
positive regulation of dipeptide transmembrane transport	Carbonic anhydrase 2	Bos taurus (cattle)
response to bacterium	Carbonic anhydrase 3	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 3	Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of bitter taste	Carbonic anhydrase 6	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 6	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)
positive regulation of synaptic transmission, GABAergic	Carbonic anhydrase 7	Homo sapiens (human)
positive regulation of cellular pH reduction	Carbonic anhydrase 7	Homo sapiens (human)
neuron cellular homeostasis	Carbonic anhydrase 7	Homo sapiens (human)
regulation of chloride transport	Carbonic anhydrase 7	Homo sapiens (human)
regulation of intracellular pH	Carbonic anhydrase 7	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 7	Homo sapiens (human)
nucleobase-containing compound metabolic process	Thiopurine S-methyltransferase	Homo sapiens (human)
xenobiotic metabolic process	Thiopurine S-methyltransferase	Homo sapiens (human)
methylation	Thiopurine S-methyltransferase	Homo sapiens (human)
xenobiotic catabolic process	Thiopurine S-methyltransferase	Homo sapiens (human)
response to hypoxia	Carbonic anhydrase 9	Homo sapiens (human)
morphogenesis of an epithelium	Carbonic anhydrase 9	Homo sapiens (human)
response to xenobiotic stimulus	Carbonic anhydrase 9	Homo sapiens (human)
response to testosterone	Carbonic anhydrase 9	Homo sapiens (human)
secretion	Carbonic anhydrase 9	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 9	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 14	Homo sapiens (human)
carbohydrate metabolic process	Sialidase-3	Homo sapiens (human)
ganglioside catabolic process	Sialidase-3	Homo sapiens (human)
oligosaccharide catabolic process	Sialidase-3	Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathway	Sialidase-3	Homo sapiens (human)
glycosphingolipid catabolic process	Sialidase-3	Homo sapiens (human)
negative regulation of clathrin-dependent endocytosis	Sialidase-3	Homo sapiens (human)
response to bacterium	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
zinc ion binding	Carbonic anhydrase 12	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 12	Homo sapiens (human)
arylesterase activity	Carbonic anhydrase 1	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 1	Homo sapiens (human)
protein binding	Carbonic anhydrase 1	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 1	Homo sapiens (human)
hydro-lyase activity	Carbonic anhydrase 1	Homo sapiens (human)
cyanamide hydratase activity	Carbonic anhydrase 1	Homo sapiens (human)
arylesterase activity	Carbonic anhydrase 2	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 2	Homo sapiens (human)
protein binding	Carbonic anhydrase 2	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 2	Homo sapiens (human)
cyanamide hydratase activity	Carbonic anhydrase 2	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 2	Bos taurus (cattle)
cyanamide hydratase activity	Carbonic anhydrase 2	Bos taurus (cattle)
carbonate dehydratase activity	Carbonic anhydrase 3	Homo sapiens (human)
protein binding	Carbonic anhydrase 3	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 3	Homo sapiens (human)
nickel cation binding	Carbonic anhydrase 3	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 6	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 6	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 7	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 7	Homo sapiens (human)
protein binding	Thiopurine S-methyltransferase	Homo sapiens (human)
thiopurine S-methyltransferase activity	Thiopurine S-methyltransferase	Homo sapiens (human)
S-adenosyl-L-methionine binding	Thiopurine S-methyltransferase	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 9	Homo sapiens (human)
protein binding	Carbonic anhydrase 9	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 9	Homo sapiens (human)
molecular function activator activity	Carbonic anhydrase 9	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 4	Bos taurus (cattle)
zinc ion binding	Carbonic anhydrase 14	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 14	Homo sapiens (human)
exo-alpha-sialidase activity	Sialidase-3	Homo sapiens (human)
protein binding	Sialidase-3	Homo sapiens (human)
alpha-sialidase activity	Sialidase-3	Homo sapiens (human)
exo-alpha-(2->3)-sialidase activity	Sialidase-3	Homo sapiens (human)
exo-alpha-(2->6)-sialidase activity	Sialidase-3	Homo sapiens (human)
exo-alpha-(2->8)-sialidase activity	Sialidase-3	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
plasma membrane	Carbonic anhydrase 12	Homo sapiens (human)
membrane	Carbonic anhydrase 12	Homo sapiens (human)
basolateral plasma membrane	Carbonic anhydrase 12	Homo sapiens (human)
apical plasma membrane	Carbonic anhydrase 12	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 12	Homo sapiens (human)
cytosol	Carbonic anhydrase 1	Homo sapiens (human)
extracellular exosome	Carbonic anhydrase 1	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 2	Homo sapiens (human)
cytosol	Carbonic anhydrase 2	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 2	Homo sapiens (human)
myelin sheath	Carbonic anhydrase 2	Homo sapiens (human)
apical part of cell	Carbonic anhydrase 2	Homo sapiens (human)
extracellular exosome	Carbonic anhydrase 2	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 2	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 2	Homo sapiens (human)
apical part of cell	Carbonic anhydrase 2	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 2	Bos taurus (cattle)
plasma membrane	Carbonic anhydrase 2	Bos taurus (cattle)
cytosol	Carbonic anhydrase 3	Homo sapiens (human)
cytosol	Carbonic anhydrase 3	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 3	Homo sapiens (human)
extracellular region	Carbonic anhydrase 6	Homo sapiens (human)
extracellular space	Carbonic anhydrase 6	Homo sapiens (human)
cytosol	Carbonic anhydrase 6	Homo sapiens (human)
extracellular exosome	Carbonic anhydrase 6	Homo sapiens (human)
extracellular space	Carbonic anhydrase 6	Homo sapiens (human)
mitochondrial matrix	Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)
mitochondrion	Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)
mitochondrion	Carbonic anhydrase 5A, mitochondrial	Homo sapiens (human)
cytosol	Carbonic anhydrase 7	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 7	Homo sapiens (human)
cytosol	Thiopurine S-methyltransferase	Homo sapiens (human)
nucleolus	Carbonic anhydrase 9	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 9	Homo sapiens (human)
membrane	Carbonic anhydrase 9	Homo sapiens (human)
basolateral plasma membrane	Carbonic anhydrase 9	Homo sapiens (human)
microvillus membrane	Carbonic anhydrase 9	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 9	Homo sapiens (human)
side of membrane	Carbonic anhydrase 4	Bos taurus (cattle)
plasma membrane	Carbonic anhydrase 14	Homo sapiens (human)
membrane	Carbonic anhydrase 14	Homo sapiens (human)
basolateral plasma membrane	Carbonic anhydrase 14	Homo sapiens (human)
apical plasma membrane	Carbonic anhydrase 14	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 14	Homo sapiens (human)
lysosomal membrane	Sialidase-3	Homo sapiens (human)
plasma membrane	Sialidase-3	Homo sapiens (human)
caveola	Sialidase-3	Homo sapiens (human)
external side of plasma membrane	Sialidase-3	Homo sapiens (human)
early endosome membrane	Sialidase-3	Homo sapiens (human)
recycling endosome membrane	Sialidase-3	Homo sapiens (human)
membrane	Sialidase-3	Homo sapiens (human)
lysosome	Sialidase-3	Homo sapiens (human)
cytoplasm	Sialidase-3	Homo sapiens (human)
mitochondrion	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
mitochondrial matrix	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
mitochondrion	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 5B, mitochondrial	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (248)

Assay ID	Title	Year	Journal	Article
AID1794808	Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).	2014	Journal of biomolecular screening, Jul, Volume: 19, Issue:6	A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808	Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1296008	Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening	2020	SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1	Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986	P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987	P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810	Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign	2010	Endocrinology, Jul, Volume: 151, Issue:7	A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845	Primary qHTS for Inhibitors of ATXN expression
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812	Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign	2010	Endocrinology, Jul, Volume: 151, Issue:7	A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635	Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504749	qHTS profiling for inhibitors of Plasmodium falciparum proliferation	2011	Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043	Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID427125	Inhibition of human recombinant carbonic anhydrase 1 by stopped-flow CO2 hydrase method	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
AID244146	Selectivity for Carbonic anhydrase II to that of Carbonic anhydrase V	2004	Bioorganic & medicinal chemistry letters, Nov-15, Volume: 14, Issue:22	Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
AID1142836	Inhibition of Legionella pneumophilia subsp. Pneumophila strain Philadelphia-1 carbonic anhydrase-1 assessed as CO2 hydrase activity by stopped-flow assay	2014	Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11	Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1453413	Inhibition of human carbonic anhydrase-2 assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 secs by stopped-flow assay
AID436565	Inhibition of cloned Stylophora pistillata alpha-CA expressed in human HEK293 cells by stopped-flow CO2 assay	2009	Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14	Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
AID1287520	Inhibition of recombinant Enterobacter sp. B13 beta carbonic anhydrase incubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7	Sulfonamide inhibition studies of the β-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13.
AID306204	Antimicrobial activity against Mycobacterium smegmatis	2007	Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5	Anti-mycobacterial activity of a bis-sulfonamide.
AID1188138	Inhibition of Porphyromonas gingivalis Gamma-carbonic anhydrase compound preincubated for 15 mins by stopped flow CO2 hydrase assay method	2014	Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17	Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the β-class (PgiCAb) versus the γ-class (PgiCA) enzymes.
AID306207	Antimicrobial activity against Staphylococcus aureus	2007	Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5	Anti-mycobacterial activity of a bis-sulfonamide.
AID1291355	Inhibition of recombinant Vibrio cholerae beta-carbonic anhydrase preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8	Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID1195371	Inhibition of Anopheles gambiae carbonic anhydrase pre-incubated for 15 mins by stopped-flow CO2 hydration assay	2015	Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10	The β-carbonic anhydrase from the malaria mosquito Anopheles gambiae is highly inhibited by sulfonamides.
AID459696	Inhibition of Brucella suis CA1 expressed in Escherichia coli BL21(DE3) by stopped-flow CO2-hydration assay	2010	Journal of medicinal chemistry, Mar-11, Volume: 53, Issue:5	Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
AID306205	Antimicrobial activity against Candida albicans	2007	Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5	Anti-mycobacterial activity of a bis-sulfonamide.
AID47936	Inhibition of human carbonic anhydrase II	2003	Bioorganic & medicinal chemistry letters, Mar-24, Volume: 13, Issue:6	Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
AID1809971	Inhibition of recombinant human CA1 using 4-nitrophenylacetate as substrate by esterase assay	2021	Bioorganic & medicinal chemistry letters, 12-01, Volume: 53	Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors.
AID1188135	Inhibition of human recombinant Carbonic anhydrase 2 compound preincubated for 15 mins by stopped flow CO2 hydrase assay method	2014	Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17	Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the β-class (PgiCAb) versus the γ-class (PgiCA) enzymes.
AID369274	Inhibition of human recombinant carbonic anhydrase 9 catalytic domain by stopped flow CO2 hydrase assay	2009	Journal of medicinal chemistry, Feb-12, Volume: 52, Issue:3	Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
AID1434429	Inhibition of Burkholderia pseudomallei Gamma-carbonic anhydrase assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 sec by Line-Weaver Burk plot analysis
AID1278413	Inhibition of recombinant Colwellia psychrerythraea gamma carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID275806	Inhibition of full length human recombinant CA VI	2007	Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2	Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
AID1188137	Inhibition of Porphyromonas gingivalis Beta-carbonic anhydrase compound preincubated for 15 mins by stopped flow CO2 hydrase assay method	2014	Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17	Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the β-class (PgiCAb) versus the γ-class (PgiCA) enzymes.
AID275808	Inhibition of human recombinant cytosolic isozyme CA II by stopped-flow CO2 hydrase method	2007	Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2	Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
AID711212	Inhibition of recombinant Vibrio cholerae carbonic anhydrase expressed in Escherichia coli (DE3) preincubated for 15 mins by stopped-flow CO2 hydrase assay	2012	Journal of medicinal chemistry, Dec-13, Volume: 55, Issue:23	DNA cloning, characterization, and inhibition studies of an α-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1190065	Inhibition of Plasmodium falciparum Eta-carbonic anhydrase pre-incubated for 15 mins before CO2 substrate addition by stopped-flow CO2 hydration assay	2015	Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3	Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.
AID427123	Inhibition of Cryptococcus neoformans recombinant Can2 by stopped-flow CO2 hydration assay	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
AID1628038	Inhibition of recombinant Plasmodium falciparum eta-carbonic anhydrase (181 to 538 residues) expressed in Escherichia coli artic express (DE3) preincubated for 15 mins by stop flow CO2 hydrase assay	2016	Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17	Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
AID1434428	Inhibition of human carbonic anhydrase 2 assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 sec by Line-Weaver Burk plot analysis
AID552129	Inhibition of human recombinant CA6 by stopped-flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2	Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID1240214	Inhibition of Nostoc commune gamma carbonic anhydrase by CO2 hydration assay	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID1275913	Inhibition of human Carbonic anhydrase1 using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5	Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1061069	Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1	Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.
AID1240216	Inhibition of Methanosarcina thermophila recombinant gamma carbonic anhydrase by stopped flow CO2 hydrase assay method	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID369273	Inhibition of human full length recombinant carbonic anhydrase 6 by stopped flow CO2 hydrase assay	2009	Journal of medicinal chemistry, Feb-12, Volume: 52, Issue:3	Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
AID1142837	Inhibition of Legionella pneumophilia subsp. Pneumophila strain Philadelphia-1 carbonic anhydrase-2 assessed as CO2 hydrase activity by stopped-flow assay	2014	Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11	Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID238316	Ki value against human carbonic anhydrase XII (hCA XII)	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
AID414956	Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration method	2009	Journal of medicinal chemistry, Apr-23, Volume: 52, Issue:8	Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
AID1307761	Binding affinity to GST-fused human carbonic anhydrase-2 expressed in Escherichia coli BL21 codon plus cells assessed as dissociation constant by SPR method	2016	Journal of medicinal chemistry, 05-12, Volume: 59, Issue:9	Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.
AID239102	Inhibitory constant against catalytic domain of human carbonic anhydrase IX	2005	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 15, Issue:17	Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
AID238256	Ki value against human carbonic anhydrase VII	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
AID299243	Inhibition of human carbonic anhydrase 2 by stopped-flow CO2 hydrase assay	2007	Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
AID1307764	Binding affinity to bovine carbonic anhydrase-2 assessed as association kinetic constant by SPR method	2016	Journal of medicinal chemistry, 05-12, Volume: 59, Issue:9	Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.
AID243011	Selectivity ratio against human carbonic anhydrases II and XII	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
AID1194025	Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydrase assay	2015	Bioorganic & medicinal chemistry, Apr-15, Volume: 23, Issue:8	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.
AID1142834	Inhibition of human carbonic anhydrase-2 by stopped-flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11	Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID1061170	Inhibition of Porphyromonas gingivalis gamma-carbonic anhydrase expressed in Escherichia coli preincubated for 15 mins by stopped flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis.
AID261580	Inhibition of human recombinant carbonic anhydrase 2 by stopped-flow CO2 hydrase assay	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
AID238753	Inhibitory activity against Carbonic anhydrase I	2005	Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6	Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
AID1240215	Inhibition of Pseudoalteromonas haloplanktis gamma carbonic anhydrase by CO2 hydration assay	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID577530	Inhibition of Brucella suis carbonic anhydrase II by spectrophotometry at pH 8.3	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
AID1275910	Inhibition of Vibrio cholerae beta-carbonic anhydrase using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5	Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1268963	Inhibition of recombinant human carbonic anhydrase-2 by stopped flow CO2 hydrase assay	2016	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2	Sulfonamide inhibition studies of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
AID669115	Inhibition of human carbonic anhydrase 2 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID1190063	Inhibition of human recombinant carbonic anhydrase 1 by stopped-flow CO2 hydration assay	2015	Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3	Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.
AID1307760	Binding affinity to GST-fused human carbonic anhydrase-2 expressed in Escherichia coli BL21 codon plus cells assessed as dissociation kinetic constant by SPR method	2016	Journal of medicinal chemistry, 05-12, Volume: 59, Issue:9	Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.
AID147479	In vitro inhibitory activity against H1N9 strain of Influenza Neuraminidase (membrane)	1997	Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25	Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
AID275809	Inhibition of catalytic domain of human recombinant CA IX	2007	Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2	Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
AID367820	Inhibition of human recombinant CA1 by stopped-flow CO2 hydrase assay	2009	Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3	Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
AID349605	Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration assay	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
AID552127	Inhibition of human recombinant CA1 by stopped-flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2	Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID369271	Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydrase assay	2009	Journal of medicinal chemistry, Feb-12, Volume: 52, Issue:3	Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
AID552131	Inhibition of Stylophora pistillata carbonic anhydrase 2 by stopped-flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2	Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID369272	Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydrase assay	2009	Journal of medicinal chemistry, Feb-12, Volume: 52, Issue:3	Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
AID238769	Inhibitory activity against Carbonic anhydrase IX	2005	Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6	Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
AID1195369	Inhibition of human carbonic anhydrase 1 pre-incubated for 15 mins by stopped-flow CO2 hydration assay	2015	Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10	The β-carbonic anhydrase from the malaria mosquito Anopheles gambiae is highly inhibited by sulfonamides.
AID1142838	Inhibition of Helicobacter pylori carbonic anhydrase by stopped-flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11	Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID241574	Inhibitory concentration against human cystolic isozyme V of Carbonic anhydrase	2004	Bioorganic & medicinal chemistry letters, Nov-15, Volume: 14, Issue:22	Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
AID29132	pI50 was determined	1992	Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18	Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID552128	Inhibition of human recombinant CA2 by stopped-flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2	Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID1278412	Inhibition of Pseudoalteromonas haloplanktis gamma carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID1307763	Binding affinity to bovine carbonic anhydrase-2 assessed as dissociation constant by SPR method	2016	Journal of medicinal chemistry, 05-12, Volume: 59, Issue:9	Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.
AID1287519	Inhibition of Vibrio cholerae beta carbonic anhydrase incubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7	Sulfonamide inhibition studies of the β-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13.
AID669117	Inhibition of Candida albicans CaNce103 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID1809973	Inhibition of recombinant human CA9 using 4-nitrophenylacetate as substrate by esterase assay	2021	Bioorganic & medicinal chemistry letters, 12-01, Volume: 53	Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors.
AID1268965	Inhibition of recombinant Thiomicrospira crunogena XCL-2 carbonic anhydrase by stopped flow CO2 hydrase assay	2016	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2	Sulfonamide inhibition studies of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
AID1307765	Binding affinity to bovine carbonic anhydrase-2 assessed as dissociation kinetic constant by SPR method	2016	Journal of medicinal chemistry, 05-12, Volume: 59, Issue:9	Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.
AID1061067	Inhibition of Porphyromonas gingivalis recombinant gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1	Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.
AID48089	Inhibitory activity against human carbonic anhydrase II (hCA II)	2003	Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16	Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a bis-sulfonamide-two heads are better than one?
AID239126	Inhibitory constant against catalytic domain of human carbonic anhydrase XII	2005	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 15, Issue:17	Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
AID256964	Inhibitory activity against human recombinant mitochondrial isozyme CA VA	2005	Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24	Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
AID238276	Ki value against human carbonic anhydrase I (hCA I)	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
AID1278409	Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydrase stopped flow assay	2016	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID261581	Inhibition of Helicobacter pylori recombinant carbonic anhydrase by stopped-flow CO2 hydrase assay	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
AID263638	Inhibition of Helicobacter pylori recombinant CA	2006	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8	Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
AID427124	Inhibition of Helicobacter pylori beta-carbonic anhydrase by stopped-flow CO2 hydration assay	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
AID1188136	Inhibition of Helicobacter pylori Beta-carbonic anhydrase compound preincubated for 15 mins by stopped flow CO2 hydrase assay method	2014	Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17	Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the β-class (PgiCAb) versus the γ-class (PgiCA) enzymes.
AID644379	Inhibition of GST-tagged astrosclera willeyana Astrosclerin-3 expressed in Escherichia coli after 15 mins preincubation by stopped flow CO2 hydration assay	2012	Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4	Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.
AID1628036	Inhibition of full length human cytosolic carbonic anhydrase 1 preincubated for 15 mins by stop flow CO2 hydrase assay	2016	Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17	Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
AID669120	Antimicrobial activity against Malassezia furfur CBS 9569 after 7 days	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID612731	Inhibition of Salmonella Typhimurium recombinant carbonic anhydrase 1 at pH 8.3 by stopped flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16	Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
AID1809104	Inhibition of recombinant human carbonic anhydrase 2 using 4-nitrophenylacetate as substrate	2021	Bioorganic & medicinal chemistry letters, 11-01, Volume: 51	Novel carbohydrate-based sulfonamide derivatives as selective carbonic anhydrase II inhibitors: Synthesis, biological and molecular docking analysis.
AID1268964	Inhibition of recombinant Sulfurihydrogenibium yellowstonense YO3AOP1 carbonic anhydrase by stopped flow CO2 hydrase assay	2016	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2	Sulfonamide inhibition studies of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
AID1204106	Inhibition of recombinant Streptococcus mutans UA159 beta-carbonic anhydrase expressed in Escherichia coli Arctic cells preincubated for 15 mins by stopped flow CO2 hydrase assay	2015	Bioorganic & medicinal chemistry letters, Jun-01, Volume: 25, Issue:11	Sulfonamide inhibition study of the β-class carbonic anhydrase from the caries producing pathogen Streptococcus mutans.
AID470873	Inhibition of carbonic anhydrase 2 assessed as inhibition of carbon dioxide hydration	2009	European journal of medicinal chemistry, Sep, Volume: 44, Issue:9	A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method.
AID1278411	Inhibition of Nostoc commune gamma carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID725956	Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration assay	2013	Journal of medicinal chemistry, Feb-28, Volume: 56, Issue:4	Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease.
AID436564	Inhibition of human recombinant CA2 by stopped-flow CO2 assay	2009	Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14	Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
AID1287517	Inhibition of human carbonic anhydrase 1 incubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7	Sulfonamide inhibition studies of the β-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13.
AID1278410	Inhibition of Porphyromonas gingivalis gamma carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 26, Issue:4	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.
AID612732	Inhibition of Salmonella Typhimurium recombinant carbonic anhydrase 2 at pH 8.3 by stopped flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16	Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
AID238300	Ki value against human carbonic anhydrase II (hCA II)	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
AID437749	Inhibition of human recombinant CA2 by stopped-flow hydration assay	2009	Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23	Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
AID644380	Inhibition of human recombinant carbonic anhydrase 1 after 15 mins by stopped flow CO2 hydration assay	2012	Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4	Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.
AID1061169	Inhibition of recombinant Methanosarcina thermophila gamma-CA CAM by stopped flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis.
AID275807	Inhibition of human recombinant cytosolic isozyme CA I by stopped-flow CO2 hydrase method	2007	Journal of medicinal chemistry, Jan-25, Volume: 50, Issue:2	Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
AID577531	Inhibition of Brucella suis carbonic anhydrase I by spectrophotometry at pH 8.3	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
AID427122	Inhibition of Candida albicans recombinant Nce103 by stopped-flow CO2 hydration assay	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
AID1809975	Selectivity ratio of IC50 for inhibition of recombinant human CA9 to IC50 for inhibition of recombinant CA2 using 4-nitrophenylacetate as substrate by esterase assay	2021	Bioorganic & medicinal chemistry letters, 12-01, Volume: 53	Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors.
AID1240217	Inhibition of human recombinant carbonic anhydrase-2 by stopped flow CO2 hydrase assay method	2015	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 25, Issue:17	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis.
AID213093	Inhibition of purified human kidney thiopurine methyltransferase (TPMT)	1986	Journal of medicinal chemistry, Mar, Volume: 29, Issue:3	Thiopurine methyltransferase: structure-activity relationships for benzoic acid inhibitors and thiophenol substrates.
AID349608	Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 3 expressed in Escherichia coli BL21 by stopped flow CO2 hydration assay	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
AID238768	Inhibitory activity against Carbonic anhydrase II	2005	Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6	Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
AID669121	Antimicrobial activity against Malassezia dermatis CBS 9145 after 7 days	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID1291363	Inhibition of recombinant Vibrio cholerae gamma-carbonic anhydrase preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8	Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID1188134	Inhibition of human recombinant Carbonic anhydrase 1 compound preincubated for 15 mins by stopped flow CO2 hydrase assay method	2014	Bioorganic & medicinal chemistry, Sep-01, Volume: 22, Issue:17	Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the β-class (PgiCAb) versus the γ-class (PgiCA) enzymes.
AID437750	Inhibition of full length Mycobacterium tuberculosis H37Rv recombinant carbonic anhydrase 2 encoded by RV3588c by stopped flow CO2 hydration assay	2009	Bioorganic & medicinal chemistry letters, Dec-01, Volume: 19, Issue:23	Carbonic anhydrase inhibitors. Characterization and inhibition studies of the most active beta-carbonic anhydrase from Mycobacterium tuberculosis, Rv3588c.
AID1061066	Inhibition of Thalassiosira weissflogii delta carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1	Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.
AID1453410	Inhibition of Francisella tularensis beta-carbonic anhydrase assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 secs by stopped-flow assay
AID48300	Inhibitory activity against human cloned carbonic anhydrase isozyme IX, by CO2 hydrase assay method.	2003	Bioorganic & medicinal chemistry letters, Mar-24, Volume: 13, Issue:6	Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
AID1453411	Inhibition of Burkholderia pseudomallei beta-carbonic anhydrase assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 secs by stopped-flow assay
AID1434427	Inhibition of recombinant human carbonic anhydrase 1 assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 sec by Line-Weaver Burk plot analysis
AID238567	Ki value against murine carbonic anhydrase XIII was determined; (not tested)	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
AID369275	Inhibition of mouse recombinant carbonic anhydrase 15 by stopped flow CO2 hydrase assay	2009	Journal of medicinal chemistry, Feb-12, Volume: 52, Issue:3	Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
AID1291357	Inhibition of recombinant human carbonic anhydrase 1 preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8	Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID48280	Inhibitory activity against bovine carbonic anhydrase isozyme IV isolated from bovine lung microsomes, by esterase assay method.	2003	Bioorganic & medicinal chemistry letters, Mar-24, Volume: 13, Issue:6	Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
AID1275911	Inhibition of Vibrio cholerae alpha-carbonic anhydrase using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5	Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID1434430	Inhibition of Vibrio cholerae Gamma-carbonic anhydrase assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 sec by Line-Weaver Burk plot analysis
AID241604	Inhibitory concentration against human cystolic isozyme II of Carbonic anhydrase	2004	Bioorganic & medicinal chemistry letters, Nov-15, Volume: 14, Issue:22	Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
AID436563	Inhibition of human recombinant CA1 by stopped-flow CO2 assay	2009	Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14	Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides.
AID1453412	Inhibition of human carbonic anhydrase-1 assessed as reduction in CO2 hydration preincubated for 15 mins followed by CO2 addition measured for 10 to 100 secs by stopped-flow assay
AID1809107	Selectivity ratio of IC50 for recombinant human carbonic anhydrase 9 using 4-nitrophenylacetate as substrate to IC50 for recombinant human carbonic anhydrase 2 using 4-nitrophenylacetate as substrate	2021	Bioorganic & medicinal chemistry letters, 11-01, Volume: 51	Novel carbohydrate-based sulfonamide derivatives as selective carbonic anhydrase II inhibitors: Synthesis, biological and molecular docking analysis.
AID238255	Ki value against human carbonic anhydrase II	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
AID263639	Selectivity for Helicobacter pylori recombinant CA over human recombinant CA2	2006	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8	Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
AID1194026	Inhibition of recombinant Methanosarcina thermophila gamma-carbonic anhydrase by stopped flow CO2 hydrase assay	2015	Bioorganic & medicinal chemistry, Apr-15, Volume: 23, Issue:8	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.
AID1275912	Inhibition of human Carbonic anhydrase2 using CO2 as substrate preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry, Mar-01, Volume: 24, Issue:5	Sulfonamide inhibition studies of the β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
AID256965	Inhibitory activity against human recombinant mitochondrial isozyme CA VB	2005	Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24	Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
AID1287518	Inhibition of human carbonic anhydrase 2 incubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-01, Volume: 26, Issue:7	Sulfonamide inhibition studies of the β-carbonic anhydrase from the newly discovered bacterium Enterobacter sp. B13.
AID299242	Inhibition of human carbonic anhydrase 1 by stopped-flow CO2 hydrase assay	2007	Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
AID669122	Antimicrobial activity against Malassezia pachydermatis CBS 6536 after 7 days	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID28731	Partition coefficient (logD2.0)	1992	Journal of medicinal chemistry, Sep-04, Volume: 35, Issue:18	Energy aspects of oil/water partition leading to the novel hydrophobic parameters for the analysis of quantitative structure-activity relationships.
AID1809974	Selectivity ratio of IC50 for inhibition of recombinant human CA1 to IC50 for inhibition of recombinant human CA2 using 4-nitrophenylacetate as substrate by esterase assay	2021	Bioorganic & medicinal chemistry letters, 12-01, Volume: 53	Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors.
AID1194024	Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydrase assay	2015	Bioorganic & medicinal chemistry, Apr-15, Volume: 23, Issue:8	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.
AID301578	Inhibition of human recombinant CA 3 assessed as CO2 hydration by stopped flow kinetic assay	2007	Bioorganic & medicinal chemistry, Dec-01, Volume: 15, Issue:23	Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides.
AID778725	Inhibition of recombinant Leishmania donovani chagasi beta-carbonic anhydrase expressed in baculovirus infected insect Sf9 cells incubated for 15 mins prior to testing by stopped flow CO2 hydrase assay	2013	Journal of medicinal chemistry, Sep-26, Volume: 56, Issue:18	Cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis.
AID612726	Inhibition of human recombinant carbonic anhydrase 2 at pH 7.5 by stopped flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16	Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
AID306208	Antimicrobial activity against Vibrio harveyi	2007	Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5	Anti-mycobacterial activity of a bis-sulfonamide.
AID263637	Inhibition of human recombinant CA2	2006	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8	Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
AID1190064	Inhibition of human recombinant carbonic anhydrase 2 by stopped-flow CO2 hydration assay	2015	Bioorganic & medicinal chemistry, Feb-01, Volume: 23, Issue:3	Sulfonamide inhibition studies of the η-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum.
AID1194028	Inhibition of recombinant Nostoc commune gamma-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydrase assay	2015	Bioorganic & medicinal chemistry, Apr-15, Volume: 23, Issue:8	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.
AID349606	Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration assay	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
AID1291358	Inhibition of recombinant human carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8	Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID552130	Inhibition of Stylophora pistillata carbonic anhydrase by stopped-flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 21, Issue:2	Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.
AID1809103	Inhibition of recombinant human carbonic anhydrase 1 using 4-nitrophenylacetate as substrate	2021	Bioorganic & medicinal chemistry letters, 11-01, Volume: 51	Novel carbohydrate-based sulfonamide derivatives as selective carbonic anhydrase II inhibitors: Synthesis, biological and molecular docking analysis.
AID257601	Displacement of DNSA from CAII in bovine erythrocytes	2005	Bioorganic & medicinal chemistry letters, Dec-15, Volume: 15, Issue:24	Synthesis and structure-activity relationships of novel benzene sulfonamides with potent binding affinity for bovine carbonic anhydrase II.
AID1142833	Inhibition of human carbonic anhydrase-1 by stopped-flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry, Jun-01, Volume: 22, Issue:11	Sulfonamide inhibition studies of two β-carbonic anhydrases from the bacterial pathogen Legionella pneumophila.
AID726232	Inhibition of Trypanosoma cruzi CL Brener recombinant alpha-carbonic anhydrase expressed in insect Sf9 cell Baculovirus system by stopped flow CO2 hydration assay	2013	Journal of medicinal chemistry, Feb-28, Volume: 56, Issue:4	Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease.
AID1307759	Binding affinity to GST-fused human carbonic anhydrase-2 expressed in Escherichia coli BL21 codon plus cells assessed as association kinetic constant by SPR method	2016	Journal of medicinal chemistry, 05-12, Volume: 59, Issue:9	Kinetic and Structural Insights into the Mechanism of Binding of Sulfonamides to Human Carbonic Anhydrase by Computational and Experimental Studies.
AID299250	Inhibition of Helicobacter pylori beta carbonic anhydrase by stopped-flow CO2 hydrase assay	2007	Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
AID239703	Inhibitory constant against human carbonic anhydrase XIV in CO2 hydrase assay	2005	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 15, Issue:17	Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.
AID1268962	Inhibition of recombinant human carbonic anhydrase-1 by stopped flow CO2 hydrase assay	2016	Bioorganic & medicinal chemistry letters, Jan-15, Volume: 26, Issue:2	Sulfonamide inhibition studies of the α-carbonic anhydrase from the gammaproteobacterium Thiomicrospira crunogena XCL-2, TcruCA.
AID744415	Inhibition of recombinant full length Candida glabrata NCE103 expressed in Escherichia coli BL21 preincubated for 15 mins by stopped-flow CO2 hydrase assay	2013	Bioorganic & medicinal chemistry letters, May-01, Volume: 23, Issue:9	Carbonic anhydrase inhibitors: inhibition of the β-class enzyme from the pathogenic yeast Candida glabrata with sulfonamides, sulfamates and sulfamides.
AID1291361	Inhibition of recombinant Vibrio cholerae alpha-carbonic anhydrase preincubated for 15 mins by stopped-flow CO2 hydration assay	2016	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8	Comparison of the sulfonamide inhibition profiles of the α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID256963	Inhibitory activity against human recombinant cytosolic CA2	2005	Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24	Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
AID1809105	Inhibition of recombinant human carbonic anhydrase 9 using 4-nitrophenylacetate as substrate	2021	Bioorganic & medicinal chemistry letters, 11-01, Volume: 51	Novel carbohydrate-based sulfonamide derivatives as selective carbonic anhydrase II inhibitors: Synthesis, biological and molecular docking analysis.
AID1809972	Inhibition of recombinant human CA2 using 4-nitrophenylacetate as substrate by esterase assay	2021	Bioorganic & medicinal chemistry letters, 12-01, Volume: 53	Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors.
AID644381	Inhibition of human recombinant carbonic anhydrase 2 after 15 mins by stopped flow CO2 hydration assay	2012	Bioorganic & medicinal chemistry, Feb-15, Volume: 20, Issue:4	Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.
AID261582	Selectivity ratio for human carbonic anhydrase 2 over Helicobacter pylori carbonic anhydrase	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
AID1195370	Inhibition of human carbonic anhydrase 2 pre-incubated for 15 mins by stopped-flow CO2 hydration assay	2015	Bioorganic & medicinal chemistry, May-15, Volume: 23, Issue:10	The β-carbonic anhydrase from the malaria mosquito Anopheles gambiae is highly inhibited by sulfonamides.
AID1061068	Inhibition of Leishmania donovani chagasi recombinant beta-carbonic anhydrase preincubated for 15 mins by stopped flow CO2 hydration assay	2014	Bioorganic & medicinal chemistry letters, Jan-01, Volume: 24, Issue:1	Sulfonamide inhibition studies of the δ-carbonic anhydrase from the diatom Thalassiosira weissflogii.
AID1628037	Inhibition of human cytosolic carbonic anhydrase 2 preincubated for 15 mins by stop flow CO2 hydrase assay	2016	Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17	Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum.
AID299249	Inhibition of Helicobacter pylori alpha carbonic anhydrase by stopped-flow CO2 hydrase assay	2007	Bioorganic & medicinal chemistry letters, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
AID577527	Inhibition of human carbonic anhydrase II by spectrophotometry at pH 7.5	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
AID669116	Inhibition of Cryptococcus neoformans Can2 preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID577526	Inhibition of human carbonic anhydrase I by spectrophotometry at pH 7.5	2011	Bioorganic & medicinal chemistry, Feb-01, Volume: 19, Issue:3	A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.
AID612725	Inhibition of human recombinant carbonic anhydrase 1 at pH 7.5 by stopped flow CO2 hydration assay	2011	Bioorganic & medicinal chemistry, Aug-15, Volume: 19, Issue:16	Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.
AID414961	Inhibition of Mycobacterium tuberculosis H37Rv recombinant beta-carbonic anhydrase 1 expressed in Escherichia coli BL21 by stopped flow CO2 hydration method	2009	Journal of medicinal chemistry, Apr-23, Volume: 52, Issue:8	Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
AID669123	Antimicrobial activity against Malassezia globosa CBS 7966 after 7 days	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID367822	Inhibition of Saccharomyces cerevisiae recombinant CA expressed in Escherichia coli by stopped-flow CO2 hydrase assay	2009	Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3	Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
AID306206	Antimicrobial activity against Escherichia coli	2007	Bioorganic & medicinal chemistry letters, Mar-01, Volume: 17, Issue:5	Anti-mycobacterial activity of a bis-sulfonamide.
AID1809106	Selectivity ratio of IC50 for recombinant human carbonic anhydrase 1 using 4-nitrophenylacetate as substrate to IC50 for recombinant human carbonic anhydrase 2 using 4-nitrophenylacetate as substrate	2021	Bioorganic & medicinal chemistry letters, 11-01, Volume: 51	Novel carbohydrate-based sulfonamide derivatives as selective carbonic anhydrase II inhibitors: Synthesis, biological and molecular docking analysis.
AID349607	Inhibition of Mycobacterium tuberculosis recombinant carbonic anhydrase 1 encoded by Rv1284 by stopped flow CO2 hydration assay	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
AID48296	Inhibitory activity against human tumor-associated transmembrane carbonic anhydrase IX.	2004	Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12	Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.
AID261579	Inhibition of human recombinant carbonic anhydrase 1 by stopped-flow CO2 hydrase assay	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
AID1194027	Inhibition of recombinant Porphyromonas gingivalis gamma-carbonic anhydrase by stopped flow CO2 hydrase assay	2015	Bioorganic & medicinal chemistry, Apr-15, Volume: 23, Issue:8	Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic cyanobacterium Nostoc commune.
AID238247	Ki value against human carbonic anhydrase I	2005	Bioorganic & medicinal chemistry letters, Feb-15, Volume: 15, Issue:4	Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
AID263636	Inhibition of human recombinant CA1	2006	Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8	Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
AID725955	Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration assay	2013	Journal of medicinal chemistry, Feb-28, Volume: 56, Issue:4	Cloning, characterization, and sulfonamide and thiol inhibition studies of an α-carbonic anhydrase from Trypanosoma cruzi, the causative agent of Chagas disease.
AID414955	Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration method	2009	Journal of medicinal chemistry, Apr-23, Volume: 52, Issue:8	Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
AID367821	Inhibition of human recombinant CA2 by stopped-flow CO2 hydrase assay	2009	Bioorganic & medicinal chemistry, Feb-01, Volume: 17, Issue:3	Carbonic anhydrase inhibitors: inhibition of the beta-class enzyme from the yeast Saccharomyces cerevisiae with sulfonamides and sulfamates.
AID669119	Inhibition of GST-tagged Malassezia globosa ATCC 96807/CBS 7966 MG-CA expressed in Escherichia coli BL21(DE3) cells preincubated for 15 mins measured for 10 to 100 sec by stopped-flow method	2012	Journal of medicinal chemistry, Apr-12, Volume: 55, Issue:7	Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target.
AID50371	Inhibitory activity against human cloned carbonic anhydrase isozyme I by esterase assay method.	2003	Bioorganic & medicinal chemistry letters, Mar-24, Volume: 13, Issue:6	Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.
AID1798985	CA Inhibition Assay from Article 10.1021/jm9000488: \\Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.\\	2009	Journal of medicinal chemistry, Apr-23, Volume: 52, Issue:8	Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate.
AID1796855	CA Inhibition Assay from Article 10.1021/jm0494826: \\Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.\\	2005	Journal of medicinal chemistry, Mar-24, Volume: 48, Issue:6	Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/membrane-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating hydrazino moieties.
AID1796582	CA Inhibition Assay from Article 10.1021/jm050483n: \\Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.\\	2005	Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24	Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
AID1798982	CA Inhibition Assay from Article 10.1021/jm9003126: \\Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.\\	2009	Journal of medicinal chemistry, May-14, Volume: 52, Issue:9	Carbonic anhydrase inhibitors. Cloning, characterization, and inhibition studies of a new beta-carbonic anhydrase from Mycobacterium tuberculosis.
AID1796552	CA Inhibition Assay from Article 10.1021/jm0512600: \\Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.\\	2006	Journal of medicinal chemistry, Mar-23, Volume: 49, Issue:6	Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
AID1798769	CA Inhibition Assay from Article 10.1021/jm801267c: \\Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.\\	2009	Journal of medicinal chemistry, Feb-12, Volume: 52, Issue:3	Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV.
AID1799266	CA Inhibition Assay from Article 10.1016/j.bmc.2009.05.002: \\Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.\\	2009	Bioorganic & medicinal chemistry, Jul-01, Volume: 17, Issue:13	Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides.
AID1795674	Neuraminidase Inhibition Assay from Article 10.1021/jm970479e: \\Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.\\	1997	Journal of medicinal chemistry, Dec-05, Volume: 40, Issue:25	Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
AID1347100	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154	Primary screen GU AMC qHTS for Zika virus inhibitors	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347083	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1508630	Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay	2021	Cell reports, 04-27, Volume: 35, Issue:4	A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347108	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347425	Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)	2019	The Journal of biological chemistry, 11-15, Volume: 294, Issue:46	Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347097	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424	RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)	2019	The Journal of biological chemistry, 11-15, Volume: 294, Issue:46	Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347101	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347096	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407	qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection	2020	ACS chemical biology, 07-17, Volume: 15, Issue:7	High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347091	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1159607	Screen for inhibitors of RMI FANCM (MM2) intereaction	2016	Journal of biomolecular screening, Jul, Volume: 21, Issue:6	A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1224817	Assays to identify small molecules inhibitory for eIF4E expression	2015	Chemistry & biology, Jul-23, Volume: 22, Issue:7	Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
AID1159537	qHTS screening for TAG (triacylglycerol) accumulators in algae	2017	Plant physiology, Aug, Volume: 174, Issue:4	Identification and Metabolite Profiling of Chemical Activators of Lipid Accumulation in Green Algae.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	6 (6.90)	18.7374
1990's	3 (3.45)	18.2507
2000's	25 (28.74)	29.6817
2010's	43 (49.43)	24.3611
2020's	10 (11.49)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	87 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Description	Relationhip Strength	Studies	Classes	Roles
4-hydroxybenzoic acid	[no description available]	medium	3	monohydroxybenzoic acid	algal metabolite; plant metabolite
anthranilic acid	[no description available]	medium	1	aminobenzoic acid	human metabolite; mouse metabolite
benzoic acid	[no description available]	medium	2	benzoic acids	algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite
3-chlorobenzoic acid	[no description available]	medium	2	monochlorobenzoic acid	drug metabolite
4-aminobenzoic acid	[no description available]	medium	3	aminobenzoic acid; aromatic amino-acid zwitterion	allergen; Escherichia coli metabolite; plant metabolite
2,6-dichlorobenzoic acid	[no description available]	medium	1	chlorobenzoic acid; dichlorobenzene	bacterial xenobiotic metabolite
2,5-dichlorobenzoic acid	[no description available]	medium	1	chlorobenzoic acid; dichlorobenzene
3,4-dichlorobenzoic acid	[no description available]	medium	1	chlorobenzoic acid
4-nitrobenzoic acid	[no description available]	medium	2	nitrobenzoic acid
4-chlorobenzoic acid	[no description available]	medium	2	monochlorobenzoic acid	bacterial xenobiotic metabolite
1-naphthoic acid	[no description available]	medium	1	naphthoic acid	bacterial xenobiotic metabolite; fungal xenobiotic metabolite
2-iodobenzoic acid	[no description available]	medium	1	2-halobenzoic acid; iodobenzoic acid
2,3,5-triiodobenzoic acid	[no description available]	medium	1	benzoic acids; organoiodine compound	antiauxins
2-naphthoic acid	[no description available]	medium	1	naphthoic acid	mouse metabolite; xenobiotic metabolite
4-tert-butylbenzoic acid	[no description available]	medium	2	alkylbenzene
3-toluic acid	[no description available]	medium	2	methylbenzoic acid	human xenobiotic metabolite
3-aminobenzoic acid	[no description available]	medium	2	aminobenzoic acid
3-hydroxybenzoic acid	[no description available]	medium	2	monohydroxybenzoic acid	bacterial metabolite; plant metabolite
4-toluic acid	[no description available]	medium	2	methylbenzoic acid
4-anisic acid	[no description available]	medium	2	methoxybenzoic acid	plant metabolite
2-toluic acid	[no description available]	medium	1	methylbenzoic acid	xenobiotic metabolite
2-chlorobenzoic acid	[no description available]	medium	1	2-halobenzoic acid; monochlorobenzoic acid	plant hormone; plant metabolite
3-nitrobenzoic acid	[no description available]	medium	2
2-fluorobenzoic acid	[no description available]	medium	1	2-halobenzoic acid; fluorobenzoic acid
4-(trifluoromethyl)benzoic acid	[no description available]	medium	1	(trifluoromethyl)benzenes; benzoic acids
4-fluorobenzoic acid	[no description available]	medium	1	fluorobenzoic acid	bacterial xenobiotic metabolite
cumic acid	[no description available]	medium	1	cumic acid	plant metabolite
3-methoxybenzoic acid	[no description available]	medium	2	methoxybenzoic acid	flavouring agent; human urinary metabolite
4-bromobenzoic acid	[no description available]	medium	1	bromobenzoic acid
3-iodobenzoate	[no description available]	medium	1	iodobenzoic acid
4-ethylbenzoic acid	[no description available]	medium	1	benzoic acids
4-cyanobenzoic acid	[no description available]	medium	1
4-carboxybenzaladehyde	[no description available]	medium	1	benzaldehydes; benzoic acids; monocarboxylic acid	plant metabolite
4-(dimethylamino)benzoic acid	[no description available]	medium	1
acedoben	[no description available]	medium	2	amidobenzoic acid
3-acetamidobenzoic acid	[no description available]	medium	3
4-aminomethylbenzoic acid	[no description available]	medium	2	benzoic acids
3-(dimethylamino)benzoic acid	[no description available]	medium	1
4-propylbenzoic acid	[no description available]	medium	1	alkylbenzene
4-azidobenzoic acid	[no description available]	medium	1
2-thiosalicylic acid	[no description available]	medium	1	sulfanylbenzoic acid	antipyretic; non-narcotic analgesic
veratric acid	[no description available]	medium	1	benzoic acids	allergen; plant metabolite
3,5-dinitrobenzoic acid	[no description available]	medium	1	benzoic acids; C-nitro compound
4-methylbenzenethiol	[no description available]	medium	1
thiophenol	[no description available]	medium	1	aryl thiol
vanillic acid	[no description available]	medium	1	methoxybenzoic acid; monohydroxybenzoic acid	plant metabolite
2-aminothiophenol	[no description available]	medium	1	aryl thiol; substituted aniline	plant metabolite
3,5-dimethylbenzoic acid	[no description available]	medium	1	dimethylbenzoic acid
isovanillic acid	[no description available]	medium	1	methoxybenzoic acid; monohydroxybenzoic acid	antibacterial agent; plant metabolite
4-nitrothiophenolate	[no description available]	medium	1
3,4-dimethoxy-5-hydroxybenzoic acid	[no description available]	medium	1	trihydroxybenzoic acid
3,5-dihydroxy-4-methoxybenzoic acid	[no description available]	medium	1	trihydroxybenzoic acid
4-nitroacetanilide	[no description available]	medium	1
sulfacetamide	[no description available]	medium	2
4-acetylbenzoic acid	[no description available]	medium	1
3,5-diaminobenzoic acid	[no description available]	medium	1
2-deoxy-2,3-dehydro-n-acetylneuraminic acid	[no description available]	medium	1	N-acetylneuraminic acids
4-guanidinobenzoate	[no description available]	medium	1	benzoic acids; guanidines
bana 113	[no description available]	medium	1
bana-108	[no description available]	medium	1
acetazolamide	[no description available]	medium	49	monocarboxylic acid amide; sulfonamide; thiadiazoles	anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
dichlorphenamide	[no description available]	medium	47	dichlorobenzene; sulfonamide	antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor; ophthalmology drug
ethoxzolamide	[no description available]	medium	47	aromatic ether; benzothiazoles; sulfonamide	antiglaucoma drug; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
mafenide	[no description available]	medium	47	aromatic amine
methazolamide	[no description available]	medium	47	sulfonamide; thiadiazoles
sulfanilamide	[no description available]	medium	47	substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor
4-amino-6-chloro-1,3-benzenedisulfonamide	[no description available]	medium	47	sulfonamide
disulphane	[no description available]	medium	20
brinzolamide	[no description available]	medium	48	sulfonamide; thienothiazine	antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor
2,4-disulfamyl-5-trifluoromethylaniline	[no description available]	medium	47
2-aminobenzenesulfonamide	[no description available]	medium	29	benzenes; sulfonamide
5-amino-1,3,4-thiadiazole-2-sulfonamide	[no description available]	medium	46
naphthalenesulfonamide	[no description available]	medium	3
4-(2-aminoethyl)benzenesulfonamide	[no description available]	medium	48
dorzolamide	[no description available]	medium	49	sulfonamide; thiophenes	antiglaucoma drug; antihypertensive agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor
6-hydroxybenzothiazide-2-sulfonamide	[no description available]	medium	16
sulfaguanidine	[no description available]	medium	1	sulfonamide antibiotic	antiinfective agent
4-toluenesulfonamide	[no description available]	medium	46	sulfonamide
2-aminosulfonyl-benzoic acid methyl ester	[no description available]	medium	2	benzoate ester; methyl ester; sulfonamide	marine xenobiotic metabolite
sulpiride	[no description available]	medium	41	benzamides; N-alkylpyrrolidine; sulfonamide	antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist
benzolamide	[no description available]	medium	43
chlorzolamide	[no description available]	medium	22
topiramate	[no description available]	medium	43	cyclic ketal; ketohexose derivative; sulfamate ester	anticonvulsant; sodium channel blocker
2-benzothiazolesulfonamide	[no description available]	medium	1	benzothiazoles; sulfonamide
n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide	[no description available]	medium	41	chloroindole; organochlorine compound; sulfonamide	antineoplastic agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor
zonisamide	[no description available]	medium	40	1,2-benzoxazoles; sulfonamide	anticonvulsant; antioxidant; central nervous system drug; protective agent; T-type calcium channel blocker
ampicillin	[no description available]	medium	1	beta-lactam antibiotic; penicillin allergen; penicillin	antibacterial drug
streptomycin	[no description available]	medium	1	antibiotic antifungal drug; antibiotic fungicide; streptomycins	antibacterial drug; antifungal agrochemical; antimicrobial agent; antimicrobial drug; bacterial metabolite; protein synthesis inhibitor
4-azidosulfanilamide	[no description available]	medium	1
celecoxib	[no description available]	medium	35	organofluorine compound; pyrazoles; sulfonamide; toluenes	cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug
saccharin	[no description available]	medium	30	1,2-benzisothiazole; N-sulfonylcarboxamide	environmental contaminant; sweetening agent; xenobiotic
neoprontosil	[no description available]	medium	1
valdecoxib	[no description available]	medium	35	isoxazoles; sulfonamide	antipyretic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
2,6-dibromosulfanilamide	[no description available]	medium	5
sulthiame	[no description available]	medium	30	organic molecular entity
hydrobromic acid	[no description available]	medium	1	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
hydrochloric acid	[no description available]	medium	1	chlorine molecular entity; gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
hydrogen sulfide	[no description available]	medium	1	gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride	Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent
cyanic acid	[no description available]	medium	1	one-carbon compound; pseudohalogen oxoacid
carbonic acid	[no description available]	medium	1	carbon oxoacid; chalcocarbonic acid	mouse metabolite
hydrogen cyanide	[no description available]	medium	1	hydracid; one-carbon compound	Escherichia coli metabolite; human metabolite; poison
thiocyanic acid	[no description available]	medium	1	hydracid; one-carbon compound; organosulfur compound	Escherichia coli metabolite
nitric acid	[no description available]	medium	1	nitrogen oxoacid	protic solvent; reagent
sulfurous acid	[no description available]	medium	1	sulfur oxoacid
sulfuric acid	[no description available]	medium	1	sulfur oxoacid	catalyst
sulfamic acid	[no description available]	medium	1	sulfamic acids
benzenearsonic acid	[no description available]	medium	1	arsonic acids; organoarsonic acid
hydrofluoric acid	[no description available]	medium	1	hydrogen halide; mononuclear parent hydride	NMR chemical shift reference compound
nitrous acid	[no description available]	medium	1	nitrogen oxoacid
hydrazoic acid	[no description available]	medium	1	nitrogen hydride
hydroiodic acid	[no description available]	medium	1	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
benzeneboronic acid	[no description available]	medium	1	boronic acids
sulfamide	[no description available]	medium	1	sulfamides
hydrochlorothiazide	[no description available]	medium	22	benzothiadiazine; organochlorine compound; sulfonamide	antihypertensive agent; diuretic; environmental contaminant; xenobiotic
ketoconazole	[no description available]	medium	2	dichlorobenzene; dioxolane; ether; imidazoles; N-acylpiperazine; N-arylpiperazine
benzenesulfonamide	[no description available]	medium	2	sulfonamide
4-bromobenzenesulfonamide	[no description available]	medium	1
benzonidazole	[no description available]	medium	1	C-nitro compound; imidazoles; monocarboxylic acid amide	antiprotozoal drug
benzene-1-3-disulfonamide	[no description available]	medium	18	sulfonamide
1-(4-chlorophenyl)-3-(4-sulfamoylphenyl)urea	[no description available]	medium	1	sulfonamide
2-(3-pyridine)acetic acid	[no description available]	medium	1	monocarboxylic acid; pyridines	human xenobiotic metabolite
ureidosuccinic acid	[no description available]	medium	1	aspartic acid derivative; C4-dicarboxylic acid; N-carbamoyl-amino acid	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
arabinofuranosylcytosine triphosphate	[no description available]	medium	1	pyrimidine ribonucleoside monophosphate
aminoethylphosphonic acid	[no description available]	medium	1	phosphonic acids; primary amino compound; zwitterion	human metabolite; metabolite; mouse metabolite
gamma-guanidinobutyric acid	[no description available]	medium	1	guanidines; monocarboxylic acid; zwitterion	fungal metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
inositol	[no description available]	medium	1	cyclitol; hexol
pentachlorophenol	[no description available]	medium	1	aromatic fungicide; chlorophenol; organochlorine pesticide; pentachlorobenzenes	human xenobiotic metabolite
phenylalanine	[no description available]	medium	1	alpha-amino acid; aromatic amino acid	Daphnia magna metabolite
nsc-267703	[no description available]	medium	1	anthracycline
n-acetyltryptophan	[no description available]	medium	2	N-acetyl-amino acid; tryptophan derivative	metabolite
tyrphostin ag957	[no description available]	medium	1	aromatic amine
2-amino-4-phosphonobutyric acid	[no description available]	medium	1
aristolochic acid i	[no description available]	medium	1	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin
benzbromarone	[no description available]	medium	1	1-benzofurans; aromatic ketone	uricosuric drug
benzylhydrochlorothiazide	[no description available]	medium	1	benzenes; benzothiadiazine; organochlorine compound; secondary amino compound; sulfonamide
eucalyptol	[no description available]	medium	1
amberlite cg 400	[no description available]	medium	1	methyl ester; organic heteropentacyclic compound; yohimban alkaloid
stallimycin	[no description available]	medium	1
domperidone	[no description available]	medium	1	benzimidazoles; heteroarylpiperidine	antiemetic; dopaminergic antagonist
ellipticine	[no description available]	medium	1	indole alkaloid; organic heterotetracyclic compound; organonitrogen heterocyclic compound; polycyclic heteroarene	antineoplastic agent; plant metabolite
glyphosate	[no description available]	medium	1	glycine derivative; phosphonic acid	agrochemical; EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor; herbicide
haloperidol	[no description available]	medium	1	aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol	antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist
miltefosine	[no description available]	medium	1	phosphocholines; phospholipid	anti-inflammatory agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antiprotozoal drug; apoptosis inducer; immunomodulator; protein kinase inhibitor
hypericin	[no description available]	medium	1
batyl alcohol	[no description available]	medium	1	alkylglycerol
imipramine	[no description available]	medium	1	dibenzoazepine	adrenergic uptake inhibitor; antidepressant; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
nsc 664704	[no description available]	medium	1	indolobenzazepine; lactam; organobromine compound	cardioprotective agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor; geroprotector
khellin	[no description available]	medium	1	furanochromone; organic heterotricyclic compound; oxacycle	anti-asthmatic agent; bronchodilator agent; cardiovascular drug; vasodilator agent
2-amino-3-phosphonopropionic acid	[no description available]	medium	1	alanine derivative; non-proteinogenic alpha-amino acid; phosphonic acids	human metabolite; metabotropic glutamate receptor antagonist
benzylsuccinic acid	[no description available]	medium	1	dicarboxylic acid	bacterial xenobiotic metabolite
beta-lapachone	[no description available]	medium	1	benzochromenone; orthoquinones	anti-inflammatory agent; antineoplastic agent; plant metabolite
mesoridazine	[no description available]	medium	1	phenothiazines; sulfoxide; tertiary amino compound	dopaminergic antagonist; first generation antipsychotic
methoxsalen	[no description available]	medium	1	aromatic ether; psoralens	antineoplastic agent; cross-linking reagent; dermatologic drug; photosensitizing agent; plant metabolite
oxaprozin	[no description available]	medium	1	1,3-oxazoles; monocarboxylic acid	analgesic; non-steroidal anti-inflammatory drug
penicillamine	[no description available]	medium	1	non-proteinogenic alpha-amino acid; thiol
pentoxifylline	[no description available]	medium	1	oxopurine
phenolsulfonphthalein	[no description available]	medium	1	2,1-benzoxathiole; arenesulfonate ester; phenols; sultone	acid-base indicator; diagnostic agent; two-colour indicator
Picrotin, analytical standard	[no description available]	medium	1	furopyran
pomiferin	[no description available]	medium	1	isoflavanones
pridinol	[no description available]	medium	1	piperidines; tertiary alcohol	antiparkinson drug; muscle relaxant
sulfaquinoxaline	[no description available]	medium	1	benzenes; sulfonamide
suramin	[no description available]	medium	1	naphthalenesulfonic acid; phenylureas; secondary carboxamide	angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug
4-methylglutamic acid	[no description available]	medium	1	amino dicarboxylic acid; glutamic acid derivative
pilocarpine hydrochloride	[no description available]	medium	1	hydrochloride
veratramine	[no description available]	medium	1	piperidine alkaloid
gibberellic acid	[no description available]	medium	1	C19-gibberellin; gibberellin monocarboxylic acid; lactone; organic heteropentacyclic compound	mouse metabolite; plant metabolite
santowhite powder	[no description available]	medium	1
fentichlor	[no description available]	medium	1	aryl sulfide; bridged diphenyl antifungal drug; monochlorobenzenes; polyphenol	antiinfective agent; drug allergen
pyrrolidonecarboxylic acid	[no description available]	medium	1	5-oxoproline; L-proline derivative; non-proteinogenic L-alpha-amino acid	algal metabolite
hexadecanolide	[no description available]	medium	1	macrolide
pamoic acid	[no description available]	medium	1	dicarboxylic acid
estradiol 17 beta-cypionate	[no description available]	medium	1	steroid ester
lithocholic acid	[no description available]	medium	1	bile acid; C24-steroid; monohydroxy-5beta-cholanic acid	geroprotector; human metabolite; mouse metabolite
jervine	[no description available]	medium	1	piperidines
bicuculline	[no description available]	medium	1	benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines	agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin
salicylurate	[no description available]	medium	1	N-acylglycine; secondary carboxamide	human xenobiotic metabolite; uremic toxin
3,5-pyridinedicarboxylic acid	[no description available]	medium	1	pyridinedicarboxylic acid
ricinine	[no description available]	medium	1	nitrile; pyridine alkaloid; pyridone
carinamide	[no description available]	medium	1
3,5-dibromotyrosine	[no description available]	medium	1	monocarboxylic acid
hematoporphyrin	[no description available]	medium	1
1H-indazol-3-amine	[no description available]	medium	1	indazoles
1,1'-methylenedi-2-naphthol	[no description available]	medium	1
tricarballylic acid	[no description available]	medium	1	tricarboxylic acid
popop	[no description available]	medium	1	1,3-oxazoles	fluorochrome
2-tert-butylhydroquinone	[no description available]	medium	1	hydroquinones	food antioxidant
7-hydroxychlorpromazine	[no description available]	medium	1	phenothiazines
cme-carbodiimide	[no description available]	medium	1
cyclacillin	[no description available]	medium	1	penicillin	antibacterial drug
strombine	[no description available]	medium	1
thymolphthalein	[no description available]	medium	1	terpene lactone
1,4,5,8-naphthalenetetracarboxylic acid	[no description available]	medium	1
(7S,9S)-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione	[no description available]	medium	1	anthracycline
hydroxyphenylazouracil	[no description available]	medium	1
canadine	[no description available]	medium	1	aromatic ether; berberine alkaloid; organic heteropentacyclic compound; oxacycle
pimonidazole	[no description available]	medium	1
flavone acetic acid	[no description available]	medium	1
trichlorophene	[no description available]	medium	1
verapamil hydrochloride	[no description available]	medium	1
cedrol	[no description available]	medium	1	cedrane sesquiterpenoid; tertiary alcohol
propazole	[no description available]	medium	1	benzimidazoles
reserpic acid	[no description available]	medium	1	yohimban alkaloid
pifexole	[no description available]	medium	1
Diphenolic acid	[no description available]	medium	1	bisphenol
Melicopidine	[no description available]	medium	1	acridines
resorufin	[no description available]	medium	1	phenoxazine
vinburnine	[no description available]	medium	1	alkaloid
pacein	[no description available]	medium	1
alantolactone	[no description available]	medium	1	naphthofuran; olefinic compound; sesquiterpene lactone	antineoplastic agent; apoptosis inducer; plant metabolite
2-(4'-methylpiperazino-1-methyl)-1,3-diazafluoranthene 1-oxide	[no description available]	medium	1
tetrandrine	[no description available]	medium	1	bisbenzylisoquinoline alkaloid; isoquinolines
stictic acid	[no description available]	medium	1	aromatic ether
gallocyanine	[no description available]	medium	1
propylsulfonic acid	[no description available]	medium	1
1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide	[no description available]	medium	1	carbodiimide; morpholines	cross-linking reagent
6,6'-dithiodinicotinic acid	[no description available]	medium	1
va 061	[no description available]	medium	1
n-acetyltyrosine, (dl)-isomer	[no description available]	medium	1	N-acetyl-amino acid; phenols; tyrosine derivative	human urinary metabolite
cinchonine	[no description available]	medium	1	(8xi)-cinchonan-9-ol; cinchona alkaloid	metabolite
n(6)-(delta(2)-isopentenyl)adenine	[no description available]	medium	1	6-isopentenylaminopurine	cytokinin
2-Phthalimidoglutaricacid	[no description available]	medium	1	glutamic acid derivative
nsc-87877	[no description available]	medium	1
methyl lithocholate	[no description available]	medium	1
nipecotic acid amide	[no description available]	medium	1	piperidinecarboxamide
dimethacrine	[no description available]	medium	1	acridines
dehydroabietic acid	[no description available]	medium	1	abietane diterpenoid; carbotricyclic compound; monocarboxylic acid	allergen; metabolite
4-deoxypyridoxine 5'-phosphate	[no description available]	medium	1
4-(phenylthio)butanoic acid	[no description available]	medium	1
bis-a-tda	[no description available]	medium	1
1-amino-2-phenylethylphosphonic acid	[no description available]	medium	1
4-fluoro-alpha-hydroxybenzeneacetic acid	[no description available]	medium	1
Isopteropodin	[no description available]	medium	1	indolizines
benzpiperylone	[no description available]	medium	1	pyrazoles; ring assembly
carboxyamido-triazole	[no description available]	medium	1
nsc 607097	[no description available]	medium	1
pacifenol	[no description available]	medium	1
n-phenyliminodiacetic acid	[no description available]	medium	2
cyc 202	[no description available]	medium	1	2,6-diaminopurines	antiviral drug; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
cystamine hydrochloride	[no description available]	medium	1
dipiperidinoethane-di-n-oxide	[no description available]	medium	1
benzyl-beta-d-xyloside	[no description available]	medium	1
2,2'-(3-methylcyclohexane-1,1-diyl)diacetic acid	[no description available]	medium	1	dicarboxylic acid
2,4-dinitrophenylacetic acid	[no description available]	medium	1
sitosterol, (3beta)-isomer	[no description available]	medium	1	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; C29-steroid; phytosterols; stigmastane sterol	anticholesteremic drug; antioxidant; mouse metabolite; plant metabolite; sterol methyltransferase inhibitor
(5-Phenyl-1,2,4-triazol-3-yl)urea	[no description available]	medium	1	benzenes
fumagillol	[no description available]	medium	1	secondary alcohol; sesquiterpenoid; spiro-epoxide	antimicrobial agent
vacquinol-1	[no description available]	medium	1
aspidospermine	[no description available]	medium	1	indole alkaloid
guaiol	[no description available]	medium	1	guaiane sesquiterpenoid
benzatropine methanesulfonate	[no description available]	medium	1
pseudoyohimbine	[no description available]	medium	1	methyl 17-hydroxy-20xi-yohimban-16-carboxylate
gant58	[no description available]	medium	1	pyridines
nsc 88915	[no description available]	medium	1
o-acetylsolasodine	[no description available]	medium	1
viroallosecurinine	[no description available]	medium	1	indolizines
4-methyl-2-quinazolinamine	[no description available]	medium	1
1-amino-9,10-dioxo-4-(3-sulfamoylanilino)anthracene-2-sulfonic acid	[no description available]	medium	1
adamantoylcytarabine	[no description available]	medium	1
6,11-dioxo-12-naphtho[2,3-b]indolizinecarboxylic acid ethyl ester	[no description available]	medium	1	naphthalenes
noscapine	[no description available]	medium	1	aromatic ether; benzylisoquinoline alkaloid; cyclic acetal; isobenzofuranone; organic heterobicyclic compound; organic heterotricyclic compound; tertiary amino compound	antineoplastic agent; antitussive; apoptosis inducer; plant metabolite
LSM-1290	[no description available]	medium	1	benzazepine alkaloid; cyclic acetal
2-glycineamide-5-chlorophenyl-2-pyrryl ketone	[no description available]	medium	1
nsc 154020	[no description available]	medium	1	N-glycosyl compound
4-[(1-naphthalenylamino)-oxomethyl]benzene-1,3-dicarboxylic acid	[no description available]	medium	1	2-hydroxyisophthalic acid
2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-one	[no description available]	medium	1	cyclic ketone; quinuclidines
5-(1,3-benzodioxol-5-yl)-N-(2,4-dimethylphenyl)-1,3,4-oxadiazol-2-amine	[no description available]	medium	1	benzodioxoles
croton factor f1	[no description available]	medium	1	phorbol ester; tertiary alpha-hydroxy ketone
medicarpin	[no description available]	medium	1	medicarpin	plant metabolite
gitoxigenin	[no description available]	medium	1	14beta-hydroxy steroid; 16beta-hydroxy steroid; 3beta-hydroxy steroid
aromoline	[no description available]	medium	1
nsc668394	[no description available]	medium	1
gant 61	[no description available]	medium	1	aminal; dialkylarylamine; pyridines; substituted aniline; tertiary amino compound	antineoplastic agent; apoptosis inducer; glioma-associated oncogene inhibitor; Hedgehog signaling pathway inhibitor
nortriptyline hydrochloride	[no description available]	medium	1	organic tricyclic compound	geroprotector
nsc 45641	[no description available]	medium	1
geraniol	[no description available]	medium	1	3,7-dimethylocta-2,6-dien-1-ol; monoterpenoid; primary alcohol	allergen; fragrance; plant metabolite; volatile oil component
aconitic acid	[no description available]	medium	1	aconitic acid	fundamental metabolite
amygdalin	[no description available]	medium	1
alpha-phenylcinnamate	[no description available]	medium	1
curcumin	[no description available]	medium	1	aromatic ether; beta-diketone; diarylheptanoid; enone; polyphenol	anti-inflammatory agent; antifungal agent; antineoplastic agent; biological pigment; contraceptive drug; dye; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; EC 1.8.1.9 (thioredoxin reductase) inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; flavouring agent; food colouring; geroprotector; hepatoprotective agent; immunomodulator; iron chelator; ligand; lipoxygenase inhibitor; metabolite; neuroprotective agent; nutraceutical; radical scavenger
ethyldimethylaminopropyl carbodiimide	[no description available]	medium	1
tamoxifen citrate	[no description available]	medium	1	citrate salt	angiogenesis inhibitor; anticoronaviral agent
eskazine	[no description available]	medium	1
nsc 336628	[no description available]	medium	1
1,3-dimethyl-8-[2-(1-pyrrolidinyl)ethylthio]-6-sulfanylidene-7H-purin-2-one	[no description available]	medium	1	oxopurine
cambinol	[no description available]	medium	1
nsc 117199	[no description available]	medium	1
mangostin	[no description available]	medium	1	aromatic ether; phenols; xanthones	antimicrobial agent; antineoplastic agent; antioxidant; plant metabolite
coumestrol	[no description available]	medium	1	coumestans; delta-lactone; polyphenol	anti-inflammatory agent; antioxidant; plant metabolite
rottlerin	[no description available]	medium	1	aromatic ketone; benzenetriol; chromenol; enone; methyl ketone	anti-allergic agent; antihypertensive agent; antineoplastic agent; apoptosis inducer; K-ATP channel agonist; metabolite
ellagic acid	[no description available]	medium	1	catechols; cyclic ketone; lactone; organic heterotetracyclic compound; polyphenol	antioxidant; EC 1.14.18.1 (tyrosinase) inhibitor; EC 2.3.1.5 (arylamine N-acetyltransferase) inhibitor; EC 2.4.1.1 (glycogen phosphorylase) inhibitor; EC 2.5.1.18 (glutathione transferase) inhibitor; EC 2.7.1.127 (inositol-trisphosphate 3-kinase) inhibitor; EC 2.7.1.151 (inositol-polyphosphate multikinase) inhibitor; EC 2.7.4.6 (nucleoside-diphosphate kinase) inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; food additive; fungal metabolite; geroprotector; plant metabolite; skin lightening agent
7,8-dimethylalloxazine	[no description available]	medium	1	7,8-dimethylbenzo[g]pteridine-2,4-dione	plant metabolite
dihydrothobainone	[no description available]	medium	1
piperic acid	[no description available]	medium	1	alpha,beta-unsaturated monocarboxylic acid; benzodioxoles	plant metabolite
abscisic acid	[no description available]	medium	1	abscisic acids
radicinin	[no description available]	medium	1	aromatic ketone
5,6-dichloro-1H-imidazo[4,5-b]pyrazine-2-carboxylic acid	[no description available]	medium	1	imidazopyrazine
hispanolone	[no description available]	medium	1
veratridine	[no description available]	medium	1
zimelidine hydrochloride	[no description available]	medium	1
chlortetracycline hydrochloride	[no description available]	medium	1
viridicatumtoxin	[no description available]	medium	1
dacarbazine	[no description available]	medium	1	dacarbazine
hematein	[no description available]	medium	1
levoplast	[no description available]	medium	1	C-nitro compound
hippuric acid	[no description available]	medium	1	N-acylglycine	human blood serum metabolite; uremic toxin
xanthine	[no description available]	medium	1	xanthine	Saccharomyces cerevisiae metabolite
atrolactic acid	[no description available]	medium	1	2-hydroxy monocarboxylic acid
etofylline	[no description available]	medium	1	oxopurine
ethacridine	[no description available]	medium	1	acridines
altretamine	[no description available]	medium	1	triamino-1,3,5-triazine
2,5-di-tert-butylhydroquinone	[no description available]	medium	1	hydroquinones
cx546	[no description available]	medium	1
diphenhydramine	[no description available]	medium	1	ether; tertiary amino compound	anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative
diuron	[no description available]	medium	1	3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene	environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic
ibuprofen	[no description available]	medium	1	monocarboxylic acid	antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; radical scavenger; xenobiotic
ipriflavone	[no description available]	medium	1	aromatic ether; isoflavones	bone density conservation agent
mebendazole	[no description available]	medium	1	aromatic ketone; benzimidazoles; carbamate ester	antinematodal drug; microtubule-destabilising agent; tubulin modulator
nocodazole	[no description available]	medium	1	aromatic ketone; benzimidazoles; carbamate ester; thiophenes	antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator
piribedil	[no description available]	medium	1	N-arylpiperazine
procainamide	[no description available]	medium	1	benzamides	anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker
prometone	[no description available]	medium	1	diamino-1,3,5-triazine; methoxy-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
propanil	[no description available]	medium	1	anilide; dichlorobenzene	herbicide
sulfadimethoxine	[no description available]	medium	1	aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic
sulfamethazine	[no description available]	medium	1	pyrimidines; sulfonamide antibiotic; sulfonamide	antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic
sulfathiazole	[no description available]	medium	1	1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic
testosterone	[no description available]	medium	1	3-hydroxy steroid	androgen
2-hydroxybenzylbenzimidazole	[no description available]	medium	1
etimizol	[no description available]	medium	1
nifenalol	[no description available]	medium	1	C-nitro compound
bis(4-hydroxyphenyl)sulfone	[no description available]	medium	1	bisphenol; sulfone	endocrine disruptor; metabolite
8-hydroxyquinoline-5-sulfonic acid	[no description available]	medium	1
salicylanilide	[no description available]	medium	1	benzanilide fungicide; salicylamides; salicylanilides
2-phenylbutyric acid	[no description available]	medium	1	benzenes; monocarboxylic acid	human xenobiotic metabolite
4,4'-dimethoxybenzophenone	[no description available]	medium	1
6-phenyl-1,3,5-triazine-2,4-diamine	[no description available]	medium	1
quinaldic acid	[no description available]	medium	1	quinolinemonocarboxylic acid	human metabolite; Saccharomyces cerevisiae metabolite
N-(2-methoxyphenyl)acetamide	[no description available]	medium	1	acetamides; methoxybenzenes
fast red b	[no description available]	medium	1
methylenebis(chloroaniline)	[no description available]	medium	1	chloroaniline	metabolite
di-(4-aminophenyl)ether	[no description available]	medium	1	aromatic ether
diphenylguanidine	[no description available]	medium	1	guanidines	allergen
4-Anilino-4-oxobutanoic acid	[no description available]	medium	1	anilide
mephobarbital	[no description available]	medium	1	barbiturates	anticonvulsant
etryptamine	[no description available]	medium	1	indoles
cinchophen	[no description available]	medium	1	quinolines
2-aminobenzothiazole	[no description available]	medium	1	benzothiazoles
nitrilotriacetic acid	[no description available]	medium	1	NTA; tricarboxylic acid	carcinogenic agent; nephrotoxic agent
n-(2-cyanoethyl)-2-phenylethylamine	[no description available]	medium	1
cyclooctane	[no description available]	medium	1
triphenyltetrazolium chloride	[no description available]	medium	1	organic chloride salt	dye; indicator
2,7-diacetylaminofluorene	[no description available]	medium	1
3,4-pyridinedicarboxylic acid	[no description available]	medium	1	pyridinedicarboxylic acid
4-(benzoylamino)-2-hydroxybenzoic acid	[no description available]	medium	1	benzamides
tropic acid	[no description available]	medium	1	3-hydroxy monocarboxylic acid	human xenobiotic metabolite
8-hydroxy-7-iodo-5-quinolinesulfonic acid	[no description available]	medium	1	hydroxyquinoline
1-acetylisatin	[no description available]	medium	1	indoledione
4-cumylphenol	[no description available]	medium	1	diarylmethane
5-methylisatin	[no description available]	medium	1
2-hydrazinobenzothiazole	[no description available]	medium	1
1,2,3-trimethoxybenzene	[no description available]	medium	1	methoxybenzenes	plant metabolite
2-amino-5-chlorobenzophenone	[no description available]	medium	1
diphenamid	[no description available]	medium	1	diarylmethane
4-(4-nitrobenzyl)pyridine	[no description available]	medium	1
5-methyl-3-phenylisoxazole-4-carboxylic acid	[no description available]	medium	1
2-acetylbenzofuran	[no description available]	medium	1
pyrazon	[no description available]	medium	1	benzenes; organochlorine compound; primary amino compound; pyridazinone	environmental contaminant; herbicide; xenobiotic
2-amino-5-nitrobenzophenone	[no description available]	medium	1
(4-tert-Butyl-phenoxy)-acetic acid	[no description available]	medium	1	monocarboxylic acid
lenacil	[no description available]	medium	1	cyclopentapyrimidine	agrochemical; environmental contaminant; herbicide; xenobiotic
chlordesmethyldiazepam	[no description available]	medium	1	benzodiazepine
2-amino-2',5-dichlorobenzophenone	[no description available]	medium	1
2-(2'-hydroxyphenyl)benzimidazole	[no description available]	medium	1
4-phthalimidobutyric acid	[no description available]	medium	1
azabutyrone	[no description available]	medium	1
2-(2-hydroxyphenyl)benzothiazole	[no description available]	medium	1	benzothiazoles; phenols	geroprotector
4,5-dichlorocatechol	[no description available]	medium	1
n-butylbenzenesulfonamide	[no description available]	medium	1	sulfonamide	neurotoxin; plant metabolite
3-phenoxybenzoic acid	[no description available]	medium	1	phenoxybenzoic acid	human xenobiotic metabolite; marine xenobiotic metabolite
2-(2-hydroxyethylmercapto)benzothiazole	[no description available]	medium	1
carboxin	[no description available]	medium	1	anilide fungicide; anilide; enamide; organosulfur heterocyclic compound; oxacycle; secondary carboxamide	antifungal agrochemical; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
meturin	[no description available]	medium	1
2-bromo-N-phenylbenzamide	[no description available]	medium	1	benzamides
4-chlorohippuric acid	[no description available]	medium	1
4-chlorophenoxyacetic acid	[no description available]	medium	1	chlorophenoxyacetic acid; monochlorobenzenes	phenoxy herbicide
2,5-dichloro-1,4-phenylenediamine	[no description available]	medium	1
metribuzin	[no description available]	medium	1	1,2,4-triazines; cyclic ketone; organic sulfide	agrochemical; environmental contaminant; herbicide; xenobiotic
2,5-dimethyl-3-furancarboxanilide	[no description available]	medium	1
moricizine hydrochloride	[no description available]	medium	1	hydrochloride	anti-arrhythmia drug
2-benzimidazolylguanidine	[no description available]	medium	1	aminoimidazole
diflubenzuron	[no description available]	medium	1	benzoylurea insecticide; monochlorobenzenes	insect sterilant
pentafluorobenzoyl-n-phenylethylamine	[no description available]	medium	1
thidiazuron	[no description available]	medium	1	ureas
phenthiazamine	[no description available]	medium	1
5,5-diphenylbarbituric acid	[no description available]	medium	1
dazoxiben hydrochloride	[no description available]	medium	1
succinylsulfanilamide	[no description available]	medium	1
benzylaminopurine	[no description available]	medium	1	6-aminopurines	cytokinin; plant metabolite
ciprofloxacin hydrochloride anhydrous	[no description available]	medium	1	hydrochloride	antibacterial drug; antiinfective agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; topoisomerase IV inhibitor
src-820 r	[no description available]	medium	1
n(4)-acetylsulfadiazine	[no description available]	medium	1	acetamides; pyrimidines; sulfonamide	marine xenobiotic metabolite
4-nitro-alpha-acetylamino-beta-hydroxypropiophenone	[no description available]	medium	1
formetamide	[no description available]	medium	1
isbufylline	[no description available]	medium	1
phenylacetylglycine	[no description available]	medium	1	monocarboxylic acid amide; monocarboxylic acid; N-acylglycine	human metabolite; mouse metabolite
N-benzoylanthranilic acid	[no description available]	medium	1	amidobenzoic acid
butinoline	[no description available]	medium	1	diarylmethane
n-(2-carboxyphenyl)glycine	[no description available]	medium	1
n,n-dimethyl-4-anisidine	[no description available]	medium	1
n-benzoylpiperidine	[no description available]	medium	1	benzamides; N-acylpiperidine
2-phenylcyclopropanecarboxylic acid	[no description available]	medium	1
n-demethylantipyrine	[no description available]	medium	1	pyrazoles; ring assembly
3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine	[no description available]	medium	1	1,2,4-triazines
2-amino-5-bromopyridine	[no description available]	medium	1
n-benzoylalanine, (dl-ala)-isomer	[no description available]	medium	1	alanine derivative; N-acyl-amino acid	metabolite
bicinchoninic acid	[no description available]	medium	1
betamipron	[no description available]	medium	1	organonitrogen compound; organooxygen compound
benzoylpropionic acid	[no description available]	medium	1	4-oxo monocarboxylic acid	hapten
Evoxine	[no description available]	medium	1	organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle
1-methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid	[no description available]	medium	1	harmala alkaloid
N-Benzylphthalimide	[no description available]	medium	1	isoindoles
pyromellitic diimide	[no description available]	medium	1
4'-bromosalicylanilide	[no description available]	medium	1
2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane	[no description available]	medium	1	bisphenol
terephthalamide	[no description available]	medium	1	benzenedicarboxamide
3(2h)-pyridazinone, 4-chloro-5-(dimethylamino)-2-phenyl-	[no description available]	medium	1
2-nitrophenylacetic acid	[no description available]	medium	1	C-nitro compound; phenylacetic acids
onychine	[no description available]	medium	1
4'-methoxyflavone	[no description available]	medium	1	ether; flavonoids
1,3-diphenyl-2-aminopropane	[no description available]	medium	1
2,2-diphenylpropionic acid	[no description available]	medium	1
3,4-dimethoxyphenylacetamide	[no description available]	medium	1
2-amino-5-bromobenzoic acid	[no description available]	medium	1
2-(1H-benzimidazol-2-yl)aniline	[no description available]	medium	1	benzimidazoles; primary arylamine; substituted aniline	geroprotector
N-Acetylhomoveratrylamine	[no description available]	medium	1	acetamides
2-chlorobenzenesulfonamide	[no description available]	medium	1
4-nitrophenyl dimethylcarbamate	[no description available]	medium	1
8-(4-tolylsulfonylamino)quinoline	[no description available]	medium	1	sulfonamide
5-methoxyindole-3-carbaldehyde	[no description available]	medium	1	indoles
2-oxo-1,2-dihydroquinoline-4-carboxylic acid	[no description available]	medium	1	quinolinemonocarboxylic acid
6-methoxy-2,3,4,9-tetrahydropyrido[3,4-b]indol-1-one	[no description available]	medium	1	beta-carbolines
pd 147953	[no description available]	medium	1
fenozan	[no description available]	medium	1
5-phenylbarbituric acid	[no description available]	medium	1
diethylpropion hydrochloride	[no description available]	medium	1	hydrochloride	appetite depressant
1-(4'-nitrophenyl)-2-aminopropane-1,3-diol	[no description available]	medium	1
beta-hydroxyphenylalanine	[no description available]	medium	1
3-(n-salicyloyl)amino-1,2,4-triazole	[no description available]	medium	1
7-chloro-4-aminoquinoline	[no description available]	medium	1	aminoquinoline
acridine-9-carboxylic acid	[no description available]	medium	1
1-phenazinecarboxylic acid	[no description available]	medium	1	aromatic carboxylic acid; monocarboxylic acid; phenazines	antifungal agent; antimicrobial agent; bacterial metabolite
4,5-diphenyl-1,5-dihydroimidazol-2-one	[no description available]	medium	1	stilbenoid
2-hydroxy-1,2-bis(methoxyphenyl)ethanone	[no description available]	medium	1
4-methyl-N-(phenylmethyl)benzenesulfonamide	[no description available]	medium	1	sulfonamide
4-n-butylaminobenzoic acid	[no description available]	medium	1	aromatic amino acid
fluoren-9-ol	[no description available]	medium	1
1-(2-carboxyethyl)uracil	[no description available]	medium	1
1-benzylindole	[no description available]	medium	1
2,3-bis(2-pyridinyl)quinoxaline	[no description available]	medium	1	quinoxaline derivative
3,3',5,5'-tetrachlorobiphenyl-4,4'-diol	[no description available]	medium	1	dichlorobenzene; hydroxybiphenyls
5-nitro-2-(1-piperidinyl)pyridine	[no description available]	medium	1	C-nitro compound
2-amino-5,7-dimethyl-1,8-naphthyridine	[no description available]	medium	1
5-benzyloxytryptophan	[no description available]	medium	1
2,5-diethoxy-4-morpholinoaniline	[no description available]	medium	1
3-hydroxy-3-phenacyloxindole	[no description available]	medium	1
carbobenzoxyphenylalanine, (dl-phe)-isomer	[no description available]	medium	1
gamma-fagarine	[no description available]	medium	1	organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle
3-carboxymethyl-6-benzyl-2,5-diketopiperazine	[no description available]	medium	1	organonitrogen compound; organooxygen compound
4-fluorobenzenesulfonamide	[no description available]	medium	1
emoxypine succinate	[no description available]	medium	1
n-carbamyltryptophan	[no description available]	medium	1
2,4,6-trimethoxyacetophenone	[no description available]	medium	1
1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole	[no description available]	medium	1
4-methyoxybenzoyl-n-glycine	[no description available]	medium	1	N-acylglycine
5-ethoxy-2-ethylmercaptobenzimidazole	[no description available]	medium	1
5(6)-1(2h)-phthalazinonyl-4(1h)-benzimidazole-2-carbamate methyl ester	[no description available]	medium	1
teomorfolin	[no description available]	medium	1
1-(1,3-benzodioxol-5-yl)-3-(1-piperidinyl)-1-propanone	[no description available]	medium	1	benzodioxoles
n-(aminocarbonyl)-2-chlorobenzenesulfonamide	[no description available]	medium	1
3-hydroxy-2-quinoxalinepropionic acid	[no description available]	medium	1
8-(methylsulfonylamino)quinoline	[no description available]	medium	1
n(4)-acetylsulfamonomethoxine	[no description available]	medium	1
8-(4-benzenesulfonylamino)quinoline	[no description available]	medium	1
methindione	[no description available]	medium	1
3,4-dihydroxybenzophenone	[no description available]	medium	1
gamma-propanol	[no description available]	medium	1
2-[(3-oxo-1-cyclohexenyl)amino]benzonitrile	[no description available]	medium	1	benzenes; nitrile
isonicotinylamide gaba	[no description available]	medium	1
5-fluorotryptamine monohydrochloride	[no description available]	medium	1
4-iodo-n-(2-(4-morpholinyl)ethyl)benzamide	[no description available]	medium	1
3-(hydroxyacetyl)indole	[no description available]	medium	1	indoles
n-(4-aminophenylsulfonyl)morpholine	[no description available]	medium	1
1H-indol-3-yl-(4-methoxyphenyl)methanone	[no description available]	medium	1	N-acylindole
2-amino-5-phenyl-1,3,4-thiadiazole	[no description available]	medium	1
N-(1-phenylethyl)acetamide	[no description available]	medium	1	acetamides; secondary carboxamide
alpha-(trichloromethyl)-4-pyridineethanol	[no description available]	medium	1	pyridines
ml 204	[no description available]	medium	1
eudesmin	[no description available]	medium	1
2-amino-4-methyl-3-nitropyridine	[no description available]	medium	1
4,4-bis(hydroxymethyl)-2-phenyl-2-oxazoline	[no description available]	medium	1
n-acetylhistidine	[no description available]	medium	1	histidine derivative; N-acetyl-amino acid
1-(1-oxo-2-phenylethyl)-4-piperidinecarboxylic acid	[no description available]	medium	1	acetamides
1-(4-chlorophenyl)-3-(2-ethoxyphenyl)urea	[no description available]	medium	1	ureas
4-methoxyxanthone	[no description available]	medium	1
N-(4-nitrophenyl)-2-phenoxyacetamide	[no description available]	medium	1	C-nitro compound
1-phenylindolin-2-one	[no description available]	medium	1
1-(benzenesulfonyl)indole	[no description available]	medium	1	sulfonamide
2,4,4,6-Tetramethyl-1,4-dihydro-3,5-pyridinedicarbonitrile	[no description available]	medium	1	dihydropyridine
pifithrin mu	[no description available]	medium	1	benzenes
2-benzyloxybenzaldehyde	[no description available]	medium	1
2-guanidine-4-methylquinazoline	[no description available]	medium	1
N-phenylcarbamic acid 2-phenoxyethyl ester	[no description available]	medium	1	carbamate ester
3,4-dihydro-2H-benzo[4,5]imidazo[2,1-b][1,3]thiazin-3-ol	[no description available]	medium	1	benzimidazoles
mequindox	[no description available]	medium	1
N-[2-(dimethylamino)ethyl]-2,2-diphenylacetamide	[no description available]	medium	1	diarylmethane
Girgensonine	[no description available]	medium	1	nitrile
Dubinidine	[no description available]	medium	1	organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle
N-[4-(methanesulfonamido)phenyl]acetamide	[no description available]	medium	1	sulfonamide
4-(2-oxazolo[4,5-b]pyridinyl)aniline	[no description available]	medium	1	1,3-oxazoles
2-[(4-nitrophenyl)methylthio]-1,3-benzoxazole	[no description available]	medium	1	benzoxazole
3-oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium	[no description available]	medium	1	pyridazines
3-(2,4-difluoroanilino)-5,5-dimethyl-1-cyclohex-2-enone	[no description available]	medium	1	substituted aniline
1-phenyl-4-pyrazolol	[no description available]	medium	1	pyrazoles; ring assembly
3-(3,5-dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide	[no description available]	medium	1	benzothiazoles
3-benzamido-2-benzofurancarboxamide	[no description available]	medium	1	benzofurans
N-[2-(4-methoxyphenyl)ethyl]acetamide	[no description available]	medium	1	acetamides
N-[2-(3-methylphenoxy)ethyl]-1H-1,2,4-triazole-5-carboxamide	[no description available]	medium	1	aromatic ether
2-(1H-indol-3-ylthio)acetic acid	[no description available]	medium	1	indoles
3-bromo-N-[2-(4-nitroanilino)ethyl]benzamide	[no description available]	medium	1	carbonyl compound; organohalogen compound
3-Methylbenzofuran-2-carboxylic acid	[no description available]	medium	1	benzofurans
5-(3,4-dimethoxyphenyl)-2H-tetrazole	[no description available]	medium	1	tetrazoles
1-(4-fluorophenyl)sulfonyl-4-(2-methoxyphenyl)piperazine	[no description available]	medium	1	piperazines
4-[[bis(2-hydroxyethyl)amino]methyl]-2,6-ditert-butylphenol	[no description available]	medium	1	alkylbenzene
2-phenylindole-3-carbaldehyde	[no description available]	medium	1
4-(2-pyridinylthio)benzofuro[3,2-d]pyrimidine	[no description available]	medium	1	aryl sulfide
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine	[no description available]	medium	1	C-nitro compound
3-[6-(4-aminophenyl)-2-phenyl-4-pyrimidinyl]aniline	[no description available]	medium	1	pyrimidines
7-methoxyisoflavone	[no description available]	medium	1	7-methoxyisoflavones
LSM-32392	[no description available]	medium	1	monoterpenoid
N-[2-(1-cyclohexenyl)ethyl]-4-(4-morpholinylmethyl)benzamide	[no description available]	medium	1	benzamides
1-(1-benzimidazolyl)-3-(1-cyclohex-3-enylmethoxy)-2-propanol	[no description available]	medium	1	benzimidazoles
N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide	[no description available]	medium	1	sulfonamide
3-acetamido-5-chloro-2-benzofurancarboxylic acid	[no description available]	medium	1	benzofurans
[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-(2,6-dimethoxyphenyl)methanone	[no description available]	medium	1	dimethoxybenzene
4-[4-methyl-6-(4-methyl-1-piperazinyl)-2-pyrimidinyl]morpholine	[no description available]	medium	1	N-arylpiperazine
haplamine	[no description available]	medium	1	organic heterotricyclic compound; organonitrogen heterocyclic compound; oxacycle
5-(3,4-dimethoxyphenyl)-1H-1,2,4-triazol-3-amine	[no description available]	medium	1	triazoles
2-ethoxy-N-[4-(4-morpholinylsulfonyl)phenyl]benzamide	[no description available]	medium	1	benzamides
2-[(5-methyl-1H-1,2,4-triazol-3-yl)thio]-1-phenylethanone	[no description available]	medium	1	aromatic ketone
1-ethyl-6-methoxy-4-oxo-3-quinolinecarboxylic acid	[no description available]	medium	1	quinolines
2-(pyridin-4-yl)-4-(pyrrolidin-1-yl)quinazoline	[no description available]	medium	1	pyridines; pyrrolidines; quinazolines
scp 1	[no description available]	medium	1
N-(3-acetamidophenyl)-4-methoxybenzamide	[no description available]	medium	1	benzamides
N-(3-acetamidophenyl)-3-chlorobenzamide	[no description available]	medium	1	benzamides
4-methoxy-N-(5-methyl-3-isoxazolyl)benzamide	[no description available]	medium	1	benzamides
N-(2-fluorophenyl)-4-phenylmethoxybenzamide	[no description available]	medium	1	benzamides
N-[4-(diethylamino)phenyl]-2-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
N-(2-furanylmethyl)-2-benzofurancarboxamide	[no description available]	medium	1	benzofurans
5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine	[no description available]	medium	1	aromatic amine; thiadiazoles
te 5	[no description available]	medium	1
2-[[anilino(oxo)methyl]amino]-4,5-dimethyl-3-thiophenecarboxamide	[no description available]	medium	1	ureas
N-(4,6-dimethyl-2-pyrimidinyl)-1,3-benzothiazol-2-amine	[no description available]	medium	1	benzothiazoles
6-methylflavone	[no description available]	medium	1
2-methoxy-N-(2-pyridinyl)benzamide	[no description available]	medium	1	benzamides
2-chloro-N-(2-phenylethyl)benzamide	[no description available]	medium	1	carbonyl compound; organohalogen compound
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide	[no description available]	medium	1	C-nitro compound
N-[2-(1-cyclohexenyl)ethyl]-4-fluorobenzamide	[no description available]	medium	1	carbonyl compound; organohalogen compound
tioxazafen	[no description available]	medium	1	1,2,4-oxadiazole; thiophenes	agrochemical; nematicide
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide	[no description available]	medium	1	aromatic amide
1-(4-Methoxyphenyl)-2-nitroethylene	[no description available]	medium	1	methoxybenzenes
brd32048	[no description available]	medium	1	methoxybenzenes; substituted aniline
2-(4-chloro-3-methylphenoxy)-N-(1H-1,2,4-triazol-5-yl)acetamide	[no description available]	medium	1	aromatic ether
2-(3,4-dichlorophenyl)imidazo[1,2-a]pyrimidine	[no description available]	medium	1	imidazoles
5-(2-phenyl-4-triazolyl)-2H-tetrazole	[no description available]	medium	1	triazoles
N-cyclohexyl-2,3-dihydroindole-1-carboxamide	[no description available]	medium	1	indolyl carboxylic acid
4-(benzylsulfanyl)thieno[2,3-d]pyrimidine	[no description available]	medium	1	aryl sulfide; benzenes; thienopyrimidine
2-methyl-5-(5-methyl-2-furanyl)-3-(1-pyrrolyl)-4-thieno[2,3-d]pyrimidinone	[no description available]	medium	1	organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound
1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide	[no description available]	medium	1	indolecarboxamide
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-3-methoxybenzamide	[no description available]	medium	1	benzamides
4-(1H-benzimidazol-2-yl)quinoline	[no description available]	medium	1	quinolines
1-(4-Chlorophenyl)-2-[(1-methyl-1H-imidazol-2-yl)thio]ethan-1-one	[no description available]	medium	1	aromatic ketone
N-(2,5-dimethylphenyl)-2-benzofurancarboxamide	[no description available]	medium	1	aromatic amide; furans
N-(4-methoxyphenyl)-2-benzofurancarboxamide	[no description available]	medium	1	aromatic amide; furans
2-(9h-xanthen-9-yl)-malonic acid	[no description available]	medium	1	xanthenes
1-(1,3-benzothiazol-2-yl)-3-phenylurea	[no description available]	medium	1	ureas
1-hydroxy-2-phenyl-1,5,6,7-tetrahydro-4H-benzimidazol-4-one	[no description available]	medium	1	imidazoles
N-(4-acetamidophenyl)-2-bromobenzamide	[no description available]	medium	1	benzamides
4-bromo-N-phenacylbenzamide	[no description available]	medium	1	aromatic ketone
1-(2,3-dihydroindol-1-yl)-2-(phenylthio)ethanone	[no description available]	medium	1	indoles
N-[6-methyl-2-(4-methylphenyl)-5-benzotriazolyl]-3-pyridinecarboxamide	[no description available]	medium	1	triazoles
N,N-dimethyl-N'-p-tolylsulfamide	[no description available]	medium	1	sulfamides	marine xenobiotic metabolite
2-(1-piperidinylmethyl)phenol	[no description available]	medium	1
2,6-bis(benzimidazol-2-yl)pyridine	[no description available]	medium	1	benzimidazoles
1-cyclohexyl-3-(2-phenylethyl)urea	[no description available]	medium	1	benzenes
1-(3,5-dichlorophenyl)-3-phenylurea	[no description available]	medium	1	ureas
1-(cyclohexylmethyl)-4-phenylpiperazine	[no description available]	medium	1	piperazines
N-phenethyl-2-furamide	[no description available]	medium	1	aromatic amide; heteroarene
paromomycin sulfate	[no description available]	medium	1
N,N,2-trimethyl-1-phenyl-5-benzimidazolesulfonamide	[no description available]	medium	1	benzimidazoles
N-(phenylmethyl)-4-(3-pyridinyl)-2-thiazolamine	[no description available]	medium	1	aralkylamine
N-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)benzenesulfonamide	[no description available]	medium	1	monoterpenoid
2-amino-5-ethyl-4-(2-furanyl)-6-propyl-3-pyridinecarbonitrile	[no description available]	medium	1	nitrile; pyridines
2-ethoxy-N-[5-(methoxymethyl)-1,3,4-thiadiazol-2-yl]benzamide	[no description available]	medium	1	benzamides
vu0099704	[no description available]	medium	1
3-(4-chlorophenyl)-2,5-dimethyl-1H-pyrazolo[1,5-a]pyrimidin-7-one	[no description available]	medium	1	pyrazoles; ring assembly
1-(2-chloro-6-fluorophenyl)-[1,2,4]triazolo[4,3-a]quinoline	[no description available]	medium	1	triazoles
2-methyl-N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)propanamide	[no description available]	medium	1	pyrroloquinoline
2-methyl-5-[(2-methyl-4-quinolinyl)thio]-1,3,4-thiadiazole	[no description available]	medium	1	aryl sulfide
5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1h-pyrido(3,2-b)indole-3-carbonitrile	[no description available]	medium	1
(3-hydroxy-5,6,7,8-tetrahydro-4H-cyclohepta[d]imidazol-2-yl)-phenylmethanone	[no description available]	medium	1	aromatic ketone
2-fluoro-N-phenacylbenzamide	[no description available]	medium	1	aromatic ketone
4-(methoxymethyl)-6-methyl-2-(2-methylanilino)-3-pyridinecarbonitrile	[no description available]	medium	1	nitrile; pyridines
1-azepanyl-[2-methoxy-4-(methylthio)phenyl]methanone	[no description available]	medium	1	carbonyl compound; thiol
GS4012 free base	[no description available]	medium	1	aryl sulfide; monomethoxybenzene; pyridines	VEGF activator
N-[1-(4-methylphenyl)-5-benzimidazolyl]acetamide	[no description available]	medium	1	benzimidazoles
2-(4-methylanilino)-1-(4-nitrophenyl)ethanone	[no description available]	medium	1	aromatic ketone
N-(2,6-dimethylphenyl)-N(2)-(3,5-dimethylphenyl)glycinamide	[no description available]	medium	1	amino acid amide; glycine derivative
2-[4-[(3-fluorophenyl)methyl]-1-piperazinyl]pyrimidine	[no description available]	medium	1	N-arylpiperazine
1-[(3,4-dimethoxyphenyl)methyl]-4-(2,3-dimethylphenyl)piperazine	[no description available]	medium	1	piperazines
4-Piperidinobenzoic acid	[no description available]	medium	1	piperidines
1-(2-methoxyphenyl)-4-(3-thiophenylmethyl)piperazine	[no description available]	medium	1	piperazines
N-(1-methyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-yl)-2-(1-pyrrolidinyl)acetamide	[no description available]	medium	1	pyrroloquinoline
4-[(1H-benzimidazol-2-ylthio)methyl]-2-thiazolamine	[no description available]	medium	1	benzimidazoles
4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide	[no description available]	medium	1	sulfonamide
N-[7-(1-oxopropyl)-2,3-dihydro-1,4-benzodioxin-6-yl]benzamide	[no description available]	medium	1	benzodioxine
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
n-(pyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine	[no description available]	medium	1
8-(3,5-dimethyl-1-pyrazolyl)quinoline	[no description available]	medium	1	quinolines
2'-nitroflavone	[no description available]	medium	1
N-(4-methoxyphenyl)-3,4-dihydroquinolin-2-amine	[no description available]	medium	1	aminoquinoline
1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one	[no description available]	medium	1	aromatic compound
vrt 532	[no description available]	medium	1
4-[[4-(2,5-dimethylphenyl)-1-piperazinyl]methyl]-2-methoxyphenol	[no description available]	medium	1	piperazines
1-piperonylpiperidine	[no description available]	medium	1
2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol	[no description available]	medium	1	aromatic amine
2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol	[no description available]	medium	1	aromatic amine
6-ethyl-5-methyl-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one	[no description available]	medium	1	pyrazolopyrimidine
N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide	[no description available]	medium	1	benzamides
N-(6-phenyl-5-imidazo[2,1-b]thiazolyl)benzamide	[no description available]	medium	1	imidazoles
2-(phenylmethylthio)-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole	[no description available]	medium	1	aryl sulfide
5-methyl-N-(4,5,6-trimethyl-2-pyrimidinyl)-1,3-benzoxazol-2-amine	[no description available]	medium	1	benzoxazole
1-(4-methoxyphenyl)-3-(6-methyl-2-pyridinyl)urea	[no description available]	medium	1	ureas
2-{[hydroxy(2-methoxyphenyl)methylidene]amino}acetic acid	[no description available]	medium	1	N-acylglycine
(4-methoxyphenyl)-(3-methyl-2-propyl-4-imidazolyl)methanone	[no description available]	medium	1	aromatic ketone
N-(3-acetamidophenyl)-2-chlorobenzamide	[no description available]	medium	1	benzamides
N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine	[no description available]	medium	1	dialkylarylamine; tertiary amino compound
2-bromo-N-(3-methoxyphenyl)benzamide	[no description available]	medium	1	benzamides
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol	[no description available]	medium	1	aromatic ether; C-nitro compound
3-[[(2,5-dimethyl-3-furanyl)-oxomethyl]amino]benzoic acid	[no description available]	medium	1	aromatic amide; furans
1-(4-ethoxyphenyl)-3-(6-quinoxalinyl)urea	[no description available]	medium	1	quinoxaline derivative
2-(dimethylsulfamoylamino)-9H-fluorene	[no description available]	medium	1	fluorenes
4-chloro-1-ethyl-3-nitro-2-quinolinone	[no description available]	medium	1	nitro compound; quinolines
4-chloro-3-nitro-1-(phenylmethyl)-2-quinolinone	[no description available]	medium	1	quinolines
2,5-dimethyl-1-(phenylmethyl)pyrrole-3,4-dicarboxaldehyde	[no description available]	medium	1	arenecarbaldehyde
2-(2-chloro-6-fluorophenyl)-1-(2,4-dihydroxyphenyl)ethanone	[no description available]	medium	1	stilbenoid
4-methyl-N-(3-nitrophenyl)-5-phenyl-3-thiophenecarboxamide	[no description available]	medium	1	aromatic amide
N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-2,2,2-trichloroacetamide	[no description available]	medium	1	triazoles
N-(2-fluoro-5-methylphenyl)-3-phenylpropanamide	[no description available]	medium	1	anilide
N-[(4-fluorophenyl)methyl]-2-thiophen-2-ylacetamide	[no description available]	medium	1	organofluorine compound
4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamide	[no description available]	medium	1	phthalazines
N-[2-(2-methylpropyl)-1,3-dioxo-5-isoindolyl]-2-furancarboxamide	[no description available]	medium	1	phthalimides
6-(1,4,5,7-tetramethyl-6-pyrrolo[3,4-d]pyridazinyl)quinoline	[no description available]	medium	1	quinolines
2-(3,4-dimethoxyphenyl)-1-(2,4,6-trihydroxyphenyl)ethanone	[no description available]	medium	1	stilbenoid
5-(3-chloro-4-methylphenyl)-3-pyridin-4-yl-1,2,4-oxadiazole	[no description available]	medium	1	oxadiazole; ring assembly
5-(phenylmethyl)-3-(2-pyridinyl)-1,2,4-oxadiazole	[no description available]	medium	1	pyridines
2-methyl-5-(1-pyrrolidinyl)isoindole-1,3-dione	[no description available]	medium	1	phthalimides
(2'-(4-aminophenyl)-(2,5'-bi-1h-benzimidazol)-5-amine)	[no description available]	medium	1	benzimidazoles
N-(4-bromo-2-fluorophenyl)-2-methyl-3-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
6,7,8,9-tetrahydro-5H-carbazole-3-carbohydrazide	[no description available]	medium	1	carbazoles
N-(3-carbamoyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-2-pyrazinecarboxamide	[no description available]	medium	1	primary carboxamide; pyrazines; secondary carboxamide
N-(1,3-benzodioxol-5-yl)-5-methyl-2-furancarboxamide	[no description available]	medium	1	benzodioxoles
1-cyclohexyl-3-(2,3-dihydro-1,4-benzodioxin-6-yl)urea	[no description available]	medium	1	benzodioxine
8-[(2-methyl-5-nitro-1,2,4-triazol-3-yl)thio]quinoline	[no description available]	medium	1	aryl sulfide
1-[2-(2-chlorophenoxy)ethyl]benzimidazole	[no description available]	medium	1	benzimidazoles
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one	[no description available]	medium	1	C-nitro compound
2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide	[no description available]	medium	1	sulfonamide
1-(4-fluorophenyl)-2-(2-pyridinylthio)ethanone	[no description available]	medium	1	aromatic ketone
3-methyl-6-(1-pyrrolidinyl)-[1,2,4]triazolo[4,3-b]pyridazine	[no description available]	medium	1	triazolopyridazine
N-(3-acetylphenyl)-2-thiophen-2-ylacetamide	[no description available]	medium	1	aromatic ketone
oncrasin-1	[no description available]	medium	1	arenecarbaldehyde; indoles; monochlorobenzenes	antineoplastic agent; apoptosis inducer
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide	[no description available]	medium	1	C-nitro compound
5-(1-methyl-2-benzimidazolyl)-2-thiophenecarboxaldehyde	[no description available]	medium	1	benzimidazoles
N-(4-anilinophenyl)-2-methylpropanamide	[no description available]	medium	1	anilide
N-(2-fluorophenyl)-3-phenylpropanamide	[no description available]	medium	1	anilide
1-[(Phenylthio)acetyl]piperidine	[no description available]	medium	1	N-acylpiperidine
N-(3-hydroxyphenyl)-5-methyl-3-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
3-(4-methoxyphenyl)-5-(4-methylphenyl)-1,2,4-oxadiazole	[no description available]	medium	1	oxadiazole; ring assembly
4-[(4-carboxy-2,6-dimethoxyphenoxy)methyl]-5-methyl-2-furancarboxylic acid	[no description available]	medium	1	trihydroxybenzoic acid
4-(4-morpholinylmethyl)-3-quinolinol	[no description available]	medium	1	quinolines
2-bromo-N-[3-(1-oxopropylamino)phenyl]benzamide	[no description available]	medium	1	benzamides
3-acetyl-2-methylbenzo[f]benzofuran-4,9-dione	[no description available]	medium	1	naphthofuran
5-(4-chlorophenyl)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-furancarboxamide	[no description available]	medium	1	aromatic amide; heteroarene
1-azepanyl-[4-[(phenylthio)methyl]phenyl]methanone	[no description available]	medium	1	benzamides
1-(5-ethyl-2,4-dihydroxyphenyl)-2-(2-fluorophenoxy)ethanone	[no description available]	medium	1	aromatic ketone
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-(2-nitrophenyl)acetamide	[no description available]	medium	1	acetamides
3,4,5-triethoxy-N-(1H-1,2,4-triazol-5-yl)benzamide	[no description available]	medium	1	benzamides
1-propylsulfonyl-4-(2-pyridinyl)piperazine	[no description available]	medium	1	piperazines; pyridines
2-(2-phenylethylthio)-3-pyridinecarboxylic acid	[no description available]	medium	1	aromatic carboxylic acid; pyridines
2-(2,3-dimethylphenoxy)-N-pyridin-4-ylacetamide	[no description available]	medium	1	aromatic ether
2-[[anilino(oxo)methyl]amino]-N-(phenylmethyl)benzamide	[no description available]	medium	1	benzamides
N-(5-acetyl-4-methyl-2-thiazolyl)-5-bromo-2-furancarboxamide	[no description available]	medium	1	thiazoles
1-cyclohexyl-3-(3-ethylphenyl)urea	[no description available]	medium	1	ureas
n-phenylpiracetam	[no description available]	medium	1
2-[(1-methyl-5-tetrazolyl)thio]-N-(2-phenylphenyl)acetamide	[no description available]	medium	1	biphenyls
N-[3-chloro-4-(1-pyrrolidinyl)phenyl]-2-nitrobenzamide	[no description available]	medium	1	benzamides
4-(3,4-dihydro-1H-isoquinolin-2-ylmethyl)-N-(2,6-dimethylphenyl)benzamide	[no description available]	medium	1	isoquinolines
5-(4-bromophenyl)-N-(2-methoxyphenyl)-2-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
3-[[(3,5-dichloro-4-ethoxyphenyl)-oxomethyl]amino]benzoic acid	[no description available]	medium	1	benzamides
1,4-bis(thiophen-2-ylsulfonyl)piperazine	[no description available]	medium	1	N-sulfonylpiperazine; thiophenes
2-bromo-N-[3-(1-oxobutylamino)phenyl]benzamide	[no description available]	medium	1	benzamides
1-(2-fluorophenyl)-4-[(6-nitro-1,3-benzodioxol-5-yl)methyl]piperazine	[no description available]	medium	1	piperazines
n-(1-benzyl-4-piperidinyl)-2,4-dichlorobenzamide	[no description available]	medium	1
2-[[2-(5-methyl-2-thiophenyl)-2-oxoethyl]thio]-3-phenyl-4-quinazolinone	[no description available]	medium	1	quinazolines
1-(2,1,3-benzothiadiazol-5-yl)-3-[4-(4-morpholinyl)phenyl]urea	[no description available]	medium	1	morpholines
ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate	[no description available]	medium	1	carbamate ester; sulfonamide
LSM-4563	[no description available]	medium	1	aromatic ketone
1-(4-chloro-3-methoxyphenyl)sulfonyl-4-phenylpiperazine	[no description available]	medium	1	piperazines
N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide	[no description available]	medium	1	sulfonamide
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide	[no description available]	medium	1	sulfonamide
1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine	[no description available]	medium	1	sulfonamide
2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide	[no description available]	medium	1	sulfonamide
4-[4-(benzenesulfonyl)-1-piperazinyl]-2-methylquinoline	[no description available]	medium	1	piperazines; pyridines
1-(6-methoxy-2,2,4-trimethyl-1-quinolinyl)-2-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]ethanone	[no description available]	medium	1	quinolines
N2-phenyl-6-[[(1-phenyl-5-tetrazolyl)thio]methyl]-1,3,5-triazine-2,4-diamine	[no description available]	medium	1	tetrazoles
2-[(4,6-dimethyl-2-pyrimidinyl)thio]-N-(4,5-diphenyl-2-oxazolyl)acetamide	[no description available]	medium	1	1,3-oxazoles
2-(4-bromophenyl)-1-[4-(2-pyridinyl)-1-piperazinyl]ethanone	[no description available]	medium	1	piperazines; pyridines
2-amino[1,3]thiazolo[4,5-d]pyrimidine-5,7-diol	[no description available]	medium	1	thiazolopyrimidine
3-[[(2-cyclohexyl-1,3-dioxo-5-isoindolyl)-oxomethyl]amino]benzoic acid	[no description available]	medium	1	aromatic amide
3-[[[3-(1-azepanylsulfonyl)-4-chlorophenyl]-oxomethyl]amino]benzoic acid	[no description available]	medium	1	benzamides
2-(4-bromophenyl)-N-(5-tert-butyl-1,3,4-thiadiazol-2-yl)acetamide	[no description available]	medium	1	acetamides
5-(1,3-benzodioxol-5-ylsulfamoyl)-2-methoxybenzoic acid	[no description available]	medium	1	methoxybenzoic acid
N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide	[no description available]	medium	1	sulfonamide
3-(2-chlorophenyl)-5-methyl-N-[4-[2-(4-morpholinyl)-2-oxoethoxy]phenyl]-4-isoxazolecarboxamide	[no description available]	medium	1	aromatic amide
N-[3-[[(4-nitrophenyl)-oxomethyl]amino]phenyl]-2-furancarboxamide	[no description available]	medium	1	benzamides
3-methyl-1,5-dithiophen-2-ylpentane-1,5-dione	[no description available]	medium	1	aromatic ketone
N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide	[no description available]	medium	1	sulfonamide
4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide	[no description available]	medium	1	sulfonamide
3-chloro-N-[4-[(1-oxo-2-phenylethyl)amino]phenyl]benzamide	[no description available]	medium	1	benzamides
N-(3,4-dimethoxyphenyl)-4-[(4-phenyl-1-piperazinyl)methyl]benzamide	[no description available]	medium	1	benzamides
stk295900	[no description available]	medium	1
1-(3-chlorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]piperazine	[no description available]	medium	1	piperazines
2-[4-[[4-(4-methoxyphenyl)-1-phthalazinyl]amino]phenyl]acetamide	[no description available]	medium	1	pyridazines; ring assembly
1-(2-fluorophenyl)-3-[5-(2-fluorophenyl)-1,3,4-thiadiazol-2-yl]urea	[no description available]	medium	1	ureas
N-[5-[(4-methoxyphenyl)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide	[no description available]	medium	1	methoxybenzenes
N-(1,3-benzodioxol-5-yl)-4-methyl-1-phthalazinamine	[no description available]	medium	1	phthalazines
SMER 28	[no description available]	medium	1	organobromine compound; quinazolines; secondary amino compound	autophagy inducer
N-[4-(4-morpholinyl)phenyl]carbamic acid butyl ester	[no description available]	medium	1	morpholines
4-(4-chlorophenoxy)-1-(4-morpholinyl)-1-butanone	[no description available]	medium	1	aromatic ether
4-(4-chlorophenoxy)-1-(1-piperidinyl)-1-butanone	[no description available]	medium	1	N-acylpiperidine
N-(3-phenylpropyl)methanesulfonamide	[no description available]	medium	1	benzenes
4-acetamido-N-(2-methoxyethyl)benzamide	[no description available]	medium	1	amidobenzoic acid
2-methyl-N-(2,3,4,5,6-pentafluorophenyl)-3-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone	[no description available]	medium	1	quinolines
5-bromo-N-(2-phenylphenyl)-2-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
2-[2-(4-chlorophenoxy)ethylthio]pyrimidine	[no description available]	medium	1	aromatic ether
3-(3-bromoanilino)-1-(5-methyl-2-furanyl)-1-propanone	[no description available]	medium	1	aralkylamine
4-[2-(4-bromo-2-chlorophenoxy)-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester	[no description available]	medium	1	piperazinecarboxylic acid
2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid	[no description available]	medium	1	benzamides
1-[2-(2-chlorophenoxy)ethoxy]-2-methoxy-4-methylbenzene	[no description available]	medium	1	methoxybenzenes
N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide	[no description available]	medium	1	sulfonamide
4-[2-[2-(4-bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine	[no description available]	medium	1	aromatic ether
N-[2-(2-phenylphenoxy)ethyl]-2-furancarboxamide	[no description available]	medium	1	biphenyls
5,6,7,8-tetrafluoro-2-(2,3,4,5,6-pentafluorophenyl)-4h-1-benzopyran-4-one	[no description available]	medium	1
2-[bis(5-methyl-2-furanyl)methyl]-6-nitrophenol	[no description available]	medium	1	nitrophenol
2-(4-nitrophenyl)-N-(2-oxolanylmethyl)-4-quinazolinamine	[no description available]	medium	1	quinazolines
2-(4-hydroxy-1,3-thiazol-2-yl)-1-phenylethan-1-one	[no description available]	medium	1	aromatic ketone
Methyl(2-furoylamino)acetic acid	[no description available]	medium	1	N-acyl-amino acid
5-nitro-8-(1-pyrrolidinyl)quinoline	[no description available]	medium	1	nitro compound; quinolines
2-(3-oxo-2,4-dihydro-1H-quinoxalin-2-yl)-N-phenylacetamide	[no description available]	medium	1	amino acid amide
2-[(4-methylphenyl)sulfonylamino]pentanoic acid	[no description available]	medium	1	sulfonamide
4,6-dimorpholino-n-(4-nitrophenyl)-1,3,5-triazin-2-amine	[no description available]	medium	1
1-[(3-chlorophenyl)methyl]-N,N-diethyl-3-piperidinecarboxamide	[no description available]	medium	1	piperidines
1-(2,6-dimethyl-1-piperidinyl)-2-phenylethanone	[no description available]	medium	1	acetamides
2-amino-7-methyl-5-oxo-4-(2,3,4-trimethoxyphenyl)-4,6,7,8-tetrahydro-1-benzopyran-3-carbonitrile	[no description available]	medium	1	methoxybenzenes
3-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]-1-phenylpyrrolidine-2,5-dione	[no description available]	medium	1	pyrrolidines
1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione	[no description available]	medium	1	pyrrolidines
4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine	[no description available]	medium	1	dialkylarylamine; tertiary amino compound
(3,5-Dimethyl-1-adamantyl)amine nitrate	[no description available]	medium	1	nitrates
1-(4-tert-butylphenoxy)-3-(1H-1,2,4-triazol-5-ylthio)-2-propanol	[no description available]	medium	1	alkylbenzene
N-[2-(1-methyl-2-pyrrolidinyl)ethyl]-2-adamantanamine	[no description available]	medium	1	N-alkylpyrrolidine
4-phenyl-N-(pyridin-4-ylmethyl)-2-butanamine	[no description available]	medium	1	aralkylamine
N-(5-nitro-2-pyridinyl)cyclopropanecarboxamide	[no description available]	medium	1	aromatic amide
3-[(4-bromophenyl)methyl]-4-(4-methoxyanilino)-4-oxobutanoic acid	[no description available]	medium	1	anilide
3-ethyl-N-(2H-tetrazol-5-yl)-1-adamantanecarboxamide	[no description available]	medium	1	aromatic amide
N-(4-propan-2-ylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide	[no description available]	medium	1	monoterpenoid
4-chloro-N-[2-(4-nitroanilino)ethyl]benzamide	[no description available]	medium	1	carbonyl compound; organohalogen compound
2-[(2,3-dihydro-1,4-benzodioxin-6-ylamino)-oxomethyl]-1-cyclohexanecarboxylic acid	[no description available]	medium	1	benzodioxine
2,4-dichloro-6-[1-(4-morpholinyl)-3-phenylprop-2-ynyl]phenol	[no description available]	medium	1	aromatic compound
2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile	[no description available]	medium	1	pyrrolidines
1-ethoxy-3-(2-methoxy-4-prop-2-enylphenoxy)-2-propanol	[no description available]	medium	1	methoxybenzenes
6-amino-4-(3-chlorophenyl)-3-methyl-1-(phenylmethyl)-4H-pyrano[2,3-c]pyrazole-5-carbonitrile	[no description available]	medium	1	organochlorine compound; pyranopyrazole
1-(2-chlorophenoxy)-3-(2-methyl-1-benzimidazolyl)-2-propanol	[no description available]	medium	1	benzimidazoles
N-[2-furanyl-(8-hydroxy-7-quinolinyl)methyl]-2-methylpropanamide	[no description available]	medium	1	hydroxyquinoline
N-(2-hydroxy-5-methylphenyl)-2-furancarboxamide	[no description available]	medium	1	aromatic amide; furans
4-amino-7,8,9,10-tetrahydro-6H-pyrimido[3,4]pyrrolo[3,5-a]azepine-11-carbonitrile	[no description available]	medium	1	organic heterobicyclic compound; organonitrogen heterocyclic compound
1-(3,5-dimethylphenyl)-3-(1H-1,2,4-triazol-5-ylthio)pyrrolidine-2,5-dione	[no description available]	medium	1	pyrrolidines
6-[(3,4-difluoroanilino)-oxomethyl]-1-cyclohex-3-enecarboxylic acid	[no description available]	medium	1	anilide
4-[(3-cyano-5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophen-2-yl)amino]-4-oxobutanoic acid	[no description available]	medium	1	organosulfur heterocyclic compound
[3-methyl-4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-thiophen-2-ylmethanone	[no description available]	medium	1	aromatic amide; thiophenes
[4-(2-methoxyphenyl)-1-piperazinyl]-[4-[(phenylthio)methyl]phenyl]methanone	[no description available]	medium	1	piperazines
N-(3,3,5-trimethylcyclohexyl)-1H-1,2,4-triazole-5-carboxamide	[no description available]	medium	1	aromatic amide; heteroarene
4-[2-nitro-5-[4-(phenylmethyl)sulfonyl-1-piperazinyl]phenyl]morpholine	[no description available]	medium	1	piperazines
5-(4-ethylsulfonyl-1-piperazinyl)-2-nitro-N-(3-pyridinylmethyl)aniline	[no description available]	medium	1	piperazines
2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide	[no description available]	medium	1	benzothiazoles
N-ethyl-N-[2-[(5-nitro-8-quinolinyl)amino]ethyl]benzenesulfonamide	[no description available]	medium	1	nitro compound; quinolines
1-(4-methoxyphenyl)-N-(4-methyl-2-pyridinyl)-5-oxo-3-pyrrolidinecarboxamide	[no description available]	medium	1	pyrrolidines
3,4,5-trimethoxy-N-[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]benzamide	[no description available]	medium	1	benzamides
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene	[no description available]	medium	1	C-nitro compound; sulfonamide; toluenes	bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector
6,3',4'-Trimethoxyflavanone	[no description available]	medium	1	ether; flavonoids
1-[4-(3-ethoxyphenoxy)butyl]imidazole	[no description available]	medium	1	aromatic ether
5-[[(1-cyclohexyl-5-tetrazolyl)thio]methyl]-3-phenyl-1,2,4-oxadiazole	[no description available]	medium	1	oxadiazole; ring assembly
2-[1-(3,4-dihydro-2H-quinolin-1-yl)-1-oxopropan-2-yl]isoindole-1,3-dione	[no description available]	medium	1	phthalimides
[4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone	[no description available]	medium	1	sulfonamide
3-(2,5-dioxo-1-pyrrolidinyl)-N-(2-methyl-1,3-dioxo-5-isoindolyl)benzamide	[no description available]	medium	1	amidobenzoic acid
6-[[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]amino]-oxomethyl]-1-cyclohex-3-enecarboxylic acid	[no description available]	medium	1	aromatic amide
2,5-dimethoxy-n-(quinolin-3-yl)benzenesulfonamide	[no description available]	medium	1	quinolines
LSM-25805	[no description available]	medium	1	isoindoles
4-ethoxy-N-(3-quinolinyl)benzenesulfonamide	[no description available]	medium	1	quinolines
3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide	[no description available]	medium	1	1-benzothiophenes
nsc 727447	[no description available]	medium	1
2-methoxy-N-[(4-methylphenyl)methyl]-2-phenylacetamide	[no description available]	medium	1	acetamides
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide	[no description available]	medium	1	C-nitro compound; thiazoles
7-(2-methoxyphenyl)-5-phenyl-1,7-dihydrotetrazolo[1,5-a]pyrimidine	[no description available]	medium	1	methoxybenzenes
N-[3-[2,5-dioxo-3-(phenylmethyl)-1-pyrrolidinyl]phenyl]acetamide	[no description available]	medium	1	pyrrolidines
3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide	[no description available]	medium	1	sulfonamide
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide	[no description available]	medium	1	C-nitro compound
2-[(4-chlorophenyl)methylthio]-N-(2-hydroxy-5-nitrophenyl)acetamide	[no description available]	medium	1	nitrophenol
2-(4-ethoxyphenyl)-N-[3-(1-imidazolyl)propyl]-4-quinolinecarboxamide	[no description available]	medium	1	quinolines
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine	[no description available]	medium	1	C-nitro compound
3,3-bis(4-hydroxyphenyl)-7-methyl-1,3-dihydro-2h-indol-2-one	[no description available]	medium	1
N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide	[no description available]	medium	1	aromatic amide
N,N,4-trimethyl-2-[[(5-methyl-2-furanyl)-oxomethyl]amino]-5-thiazolecarboxamide	[no description available]	medium	1	aromatic amide; thiazoles
ex 527	[no description available]	medium	1	carbazoles; monocarboxylic acid amide; organochlorine compound
3-[3-[(5-ethyl-[1,2,4]triazino[5,6-b]indol-3-yl)thio]propyl]-1H-benzimidazol-2-one	[no description available]	medium	1	indoles
4-methyl-2,7-diphenyl-8H-pyrido[2,3-d]pyrimidin-5-one	[no description available]	medium	1	phenylpyridine
3-methylharman	[no description available]	medium	1
1-methyl-beta-carboline-3-carboxylic acid	[no description available]	medium	1
sildenafil	[no description available]	medium	1	piperazines; pyrazolopyrimidine; sulfonamide	EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent
2-methyl-4(3h)-quinazolinone	[no description available]	medium	1
n(4)-desoxychlordiazepoxide	[no description available]	medium	1
2-amino-3-hydroxyphenazine	[no description available]	medium	1
2-styrylquinazolin-4(3h)-one	[no description available]	medium	1
2-amino-5-iodo-6-phenyl-4-pyrimidinone	[no description available]	medium	1
quininib	[no description available]	medium	1	phenols; styrylquinoline	angiogenesis inhibitor
bropirimine	[no description available]	medium	1	pyrimidines
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-1H-quinazolin-4-one	[no description available]	medium	1	quinazolines
2-[(6-ethyl-4-methyl-2-quinazolinyl)amino]-6-(methoxymethyl)-1H-pyrimidin-4-one	[no description available]	medium	1	quinazolines
diclofenac	[no description available]	medium	1	amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
propafenone	[no description available]	medium	1	aromatic ketone; secondary alcohol; secondary amino compound	anti-arrhythmia drug
1,3,4-oxadiazole	[no description available]	medium	1
oxadiazoles	[no description available]	medium	1
glucose, (beta-d)-isomer	[no description available]	medium	1	D-glucopyranose	epitope; mouse metabolite
quinine	[no description available]	medium	1	cinchona alkaloid	antimalarial; muscle relaxant; non-narcotic analgesic
probenecid	[no description available]	medium	1	benzoic acids; sulfonamide	uricosuric drug
salicin	[no description available]	medium	1	aromatic primary alcohol; aryl beta-D-glucoside; benzyl alcohols	antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; prodrug
2-toluenesulfonamide	[no description available]	medium	2
toluene	[no description available]	medium	2	methylbenzene; toluenes; volatile organic compound	cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent
2-sulfobenzoic acid	[no description available]	medium	1
p-aminohippuric acid	[no description available]	medium	1	N-acylglycine	Daphnia magna metabolite
n-methylnicotinamide	[no description available]	medium	1	pyridinecarboxamide	metabolite
niacin	[no description available]	medium	1	pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3	antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent
niacinamide	[no description available]	medium	1	pyridine alkaloid; pyridinecarboxamide; vitamin B3	anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor
1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol	[no description available]	low	0	sulfonamide
amosulalol	[no description available]	low	0	sulfonamide
ampiroxicam	[no description available]	low	0	acetal; aminopyridine; benzothiazine; etabonate ester; monocarboxylic acid amide; sulfonamide	analgesic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug; prodrug
amsacrine	[no description available]	low	0	acridines; aromatic ether; sulfonamide	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
azosemide	[no description available]	low	0	monochlorobenzenes; sulfonamide; tetrazoles; thiophenes	loop diuretic
bendroflumethiazide	[no description available]	low	0	benzothiadiazine; sulfonamide	antihypertensive agent; diuretic
benzothiazide	[no description available]	low	0	benzothiadiazine; sulfonamide	antihypertensive agent; diuretic
bumetanide	[no description available]	low	0	amino acid; benzoic acids; sulfonamide	diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
chlorthalidone	[no description available]	low	0	isoindoles; monochlorobenzenes; sulfonamide
4-chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide	[no description available]	low	0	sulfonamide
e 4031	[no description available]	low	0	sulfonamide
famotidine	[no description available]	low	0	1,3-thiazoles; guanidines; sulfonamide	anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
furosemide	[no description available]	low	0	chlorobenzoic acid; furans; sulfonamide	environmental contaminant; loop diuretic; xenobiotic
glimepiride	[no description available]	low	0	sulfonamide
n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide	[no description available]	low	0	isoquinolines; sulfonamide
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide	[no description available]	low	0	bromobenzenes; isoquinolines; olefinic compound; secondary amino compound; sulfonamide	EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
hydroxymethyltolbutamide	[no description available]	low	0	benzyl alcohols; sulfonamide; ureas	metabolite
indapamide	[no description available]	low	0	indoles; organochlorine compound; sulfonamide	antihypertensive agent; diuretic
metolazone	[no description available]	low	0	organochlorine compound; quinazolines; sulfonamide	antihypertensive agent; diuretic; ion transport inhibitor
monodansylcadaverine	[no description available]	low	0	aminonaphthalene; primary amino compound; sulfonamide; tertiary amino compound	EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor; fluorochrome; protective agent
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide	[no description available]	low	0	naphthalenes; organochlorine compound; primary amino compound; sulfonamide
naratriptan	[no description available]	low	0	heteroarylpiperidine; sulfonamide; tryptamines	serotonergic agonist; vasoconstrictor agent
nimesulide	[no description available]	low	0	aromatic ether; C-nitro compound; sulfonamide	cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	[no description available]	low	0	aromatic ether; C-nitro compound; sulfonamide	antineoplastic agent; cyclooxygenase 2 inhibitor
5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide	[no description available]	low	0	sulfonamide
phthalylsulfathiazole	[no description available]	low	0	1,3-thiazoles; dicarboxylic acid monoamide; sulfonamide antibiotic; sulfonamide
sulfadiazine	[no description available]	low	0	pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic
sotalol	[no description available]	low	0	ethanolamines; secondary alcohol; secondary amino compound; sulfonamide	anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic
SU6656	[no description available]	low	0	oxindoles; sulfonamide	antineoplastic agent; Aurora kinase inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
sulfabenzamide	[no description available]	low	0	benzenes; sulfonamide antibiotic; sulfonamide	antibacterial drug; antimicrobial drug
sulfacytine	[no description available]	low	0	benzenes; sulfonamide
sulfamerazine	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antiinfective agent; drug allergen
sulfameter	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antiinfective agent; leprostatic drug; renal agent
sulfamethizole	[no description available]	low	0	sulfonamide antibiotic; sulfonamide; thiadiazoles	antiinfective agent; antimicrobial agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
sulfamethoxazole	[no description available]	low	0	isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic
sulfamethoxypyridazine	[no description available]	low	0	pyridazines; sulfonamide antibiotic; sulfonamide	antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
sulfamonomethoxine	[no description available]	low	0	benzenes; sulfonamide
sulfanitran	[no description available]	low	0	sulfonamide
sulfaphenazole	[no description available]	low	0	primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor
sulfapyridine	[no description available]	low	0	pyridines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic
sulfisomidine	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antiinfective agent
sulfisoxazole	[no description available]	low	0	isoxazoles; sulfonamide antibiotic; sulfonamide	antibacterial drug; drug allergen
sulfoxone	[no description available]	low	0	sulfonamide
sumatriptan	[no description available]	low	0	sulfonamide; tryptamines	serotonergic agonist; vasoconstrictor agent
delavirdine	[no description available]	low	0	aminopyridine; indolecarboxamide; N-acylpiperazine; sulfonamide	antiviral drug; HIV-1 reverse transcriptase inhibitor
n-methyl-n-nitrosotoluene-p-sulfonamide	[no description available]	low	0	sulfonamide
sulfachlorpyridazine	[no description available]	low	0	organochlorine compound; pyridazines; sulfonamide	antibacterial drug; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
acetyl sulfisoxazole	[no description available]	low	0	benzenes; sulfonamide
sulfaethidole	[no description available]	low	0	benzenes; sulfonamide
sulfalene	[no description available]	low	0	pyrazines; sulfonamide antibiotic; sulfonamide
thioproperazine	[no description available]	low	0	N-alkylpiperazine; N-methylpiperazine; phenothiazines; sulfonamide	phenothiazine antipsychotic drug
carbutamide	[no description available]	low	0	benzenes; sulfonamide
glymidine	[no description available]	low	0	diether; pyrimidines; sulfonamide	hypoglycemic agent
thiazosulfone	[no description available]	low	0	sulfonamide
glybuthiazol	[no description available]	low	0	benzenes; sulfonamide
sulfanilylurea	[no description available]	low	0	benzenes; sulfonamide
metahexamide	[no description available]	low	0	benzenes; sulfonamide
clopamide	[no description available]	low	0	sulfonamide
tolcyclamide	[no description available]	low	0	sulfonamide
sulfamoxole	[no description available]	low	0	oxazole; sulfonamide antibiotic; sulfonamide	antimicrobial agent; drug allergen
sulfaethoxypyridazine	[no description available]	low	0	sulfonamide	antibacterial agent
4-((diethylamino)sulfonyl)benzoic acid	[no description available]	low	0	sulfonamide
dinsed	[no description available]	low	0	sulfonamide
amidephrine	[no description available]	low	0	sulfonamide
sulfadoxine	[no description available]	low	0	pyrimidines; sulfonamide	antibacterial drug; antimalarial
hydroxyhexamide	[no description available]	low	0	sulfonamide
asulam	[no description available]	low	0	carbamate ester; primary amino compound; substituted aniline; sulfonamide	agrochemical; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; herbicide; xenobiotic
oryzalin	[no description available]	low	0	aromatic amine; C-nitro compound; sulfonamide; tertiary amino compound	agrochemical; antimitotic; herbicide
glisoxepide	[no description available]	low	0	sulfonamide
perfluidone	[no description available]	low	0	sulfonamide
mefluidide	[no description available]	low	0	sulfonamide
clorsulon	[no description available]	low	0	benzenes; sulfonamide
agreal	[no description available]	low	0	sulfonamide
n-acetylsulfapyridine	[no description available]	low	0	sulfonamide
tirofiban	[no description available]	low	0	L-tyrosine derivative; piperidines; sulfonamide	anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist
amprenavir	[no description available]	low	0	carbamate ester; sulfonamide; tetrahydrofuryl ester	antiviral drug; HIV protease inhibitor
n(4)-acetylsulfamethoxazole	[no description available]	low	0	isoxazoles; sulfonamide	drug metabolite; marine xenobiotic metabolite
glisentide	[no description available]	low	0	sulfonamide
ebrotidine	[no description available]	low	0	sulfonamide
4-chlorobenzenesulfonamide	[no description available]	low	0	sulfonamide
N(4)-acetylsulfathiazole	[no description available]	low	0	1,3-thiazoles; acetamides; sulfonamide	marine xenobiotic metabolite
piloty's acid	[no description available]	low	0	sulfonamide
perfluorooctanesulfonamide	[no description available]	low	0	perfluorinated compound; sulfonamide	persistent organic pollutant
uk 68798	[no description available]	low	0	aromatic ether; sulfonamide; tertiary amino compound	anti-arrhythmia drug; potassium channel blocker
glyclopyramide	[no description available]	low	0	sulfonamide
fluoresone	[no description available]	low	0	sulfonamide
4-chloro-5-sulfamoylanthranilic acid	[no description available]	low	0	benzenes; sulfonamide
sulfluramid	[no description available]	low	0	sulfonamide	acaricide; environmental contaminant; insecticide; xenobiotic
n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide	[no description available]	low	0	dichlorobenzene; organofluorine compound; sulfonamide; triazoles	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
cloransulam-methyl	[no description available]	low	0	methyl ester; monochlorobenzenes; organofluorine compound; sulfonamide; triazolopyrimidines	agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide
sdds	[no description available]	low	0	benzenes; sulfonamide
4-chlorobenzenesulfonylurea	[no description available]	low	0	sulfonamide
n-(2,6-difluorophenyl)-5-methyl(1,2,4)-triazol(1,5-a)pyrimidine-2-sulfonamide	[no description available]	low	0	sulfonamide
flazasulfuron	[no description available]	low	0	pyridines; sulfonamide
bosentan anhydrous	[no description available]	low	0	primary alcohol; pyrimidines; sulfonamide	antihypertensive agent; endothelin receptor antagonist
sulfamethoxazole hydroxylamine	[no description available]	low	0	isoxazoles; sulfonamide	allergen; metabolite
gr 113808	[no description available]	low	0	indolyl carboxylate ester; piperidines; sulfonamide	serotonergic antagonist
ym 12617	[no description available]	low	0	aromatic ether; secondary amino compound; sulfonamide
dansyllysine	[no description available]	low	0	L-lysine derivative; non-proteinogenic L-alpha-amino acid; sulfonamide	epitope
almotriptan	[no description available]	low	0	indoles; sulfonamide; tertiary amine	non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent
4-nitrososulfamethoxazole	[no description available]	low	0	isoxazoles; nitroso compound; sulfonamide	allergen; metabolite
cki 7	[no description available]	low	0	isoquinolines; organochlorine compound; primary amino compound; sulfonamide	EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
fosamprenavir	[no description available]	low	0	sulfonamide	prodrug
metipamide	[no description available]	low	0	sulfonamide
jte 522	[no description available]	low	0	1,3-oxazoles; organofluorine compound; sulfonamide	cyclooxygenase 2 inhibitor
carboxytolbutamide	[no description available]	low	0	sulfonamide
tevenel	[no description available]	low	0	sulfonamide
sulfachlorpyrazine	[no description available]	low	0	sulfonamide
n(4)-acetylsulfadimethoxine	[no description available]	low	0	acetamides; pyrimidines; sulfonamide	marine xenobiotic metabolite
dronedarone	[no description available]	low	0	1-benzofurans; aromatic ether; aromatic ketone; sulfonamide; tertiary amino compound	anti-arrhythmia drug; environmental contaminant; xenobiotic
darunavir	[no description available]	low	0	carbamate ester; furofuran; sulfonamide	antiviral drug; HIV protease inhibitor
cimicoxib	[no description available]	low	0	aromatic ether; imidazoles; organochlorine compound; organofluorine compound; sulfonamide	cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
dabuzalgron	[no description available]	low	0	aromatic ether; imidazoles; monochlorobenzenes; sulfonamide	alpha-adrenergic agonist
3,4-Dichlorobenzenesulfonamide	[no description available]	low	0	sulfonamide
N-cyclooctyl-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
tolpyrramide	[no description available]	low	0	sulfonamide
acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester	[no description available]	low	0	sulfonamide
tosylphenylalanyl chloromethyl ketone	[no description available]	low	0	alpha-chloroketone; sulfonamide	alkylating agent; serine proteinase inhibitor
rosuvastatin	[no description available]	low	0	dihydroxy monocarboxylic acid; monofluorobenzenes; pyrimidines; statin (synthetic); sulfonamide	anti-inflammatory agent; antilipemic drug; cardioprotective agent; CETP inhibitor; environmental contaminant; xenobiotic
bms 214662	[no description available]	low	0	benzenes; benzodiazepine; imidazoles; nitrile; sulfonamide; thiophenes	antineoplastic agent; apoptosis inducer; EC 2.5.1.58 (protein farnesyltransferase) inhibitor
prinomastat	[no description available]	low	0	aromatic ether; hydroxamic acid; pyridines; sulfonamide; thiomorpholines	antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; matrix metalloproteinase inhibitor
glucosulfone	[no description available]	low	0	sulfonamide
1-[1-(benzenesulfonyl)-3-pyrrolyl]ethanone	[no description available]	low	0	sulfonamide
1-(4-bromo-2,5-dimethoxyphenyl)sulfonylazepane	[no description available]	low	0	sulfonamide
1-(4-chloro-3-methoxyphenyl)sulfonylazepane	[no description available]	low	0	sulfonamide
6-[(4-methylphenyl)sulfonyl]-6-azabicyclo[3.2.1]octane	[no description available]	low	0	sulfonamide
N-cyclopentyl-4-[[4-[2-furanyl(oxo)methyl]-1-piperazinyl]sulfonyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide	[no description available]	low	0	sulfonamide
2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide	[no description available]	low	0	sulfonamide
1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide	[no description available]	low	0	sulfonamide
N-(3-ethoxyphenyl)-1-(4-methoxyphenyl)sulfonyl-3-piperidinecarboxamide	[no description available]	low	0	sulfonamide
N-[4-[[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
4-[2-[1-(4-methoxyphenyl)sulfonyl-2-benzimidazolyl]ethyl]morpholine	[no description available]	low	0	sulfonamide
1-(2,5-dimethoxyphenyl)sulfonyl-N-(phenylmethyl)-4-piperidinecarboxamide	[no description available]	low	0	sulfonamide
1-[2-chloro-5-(trifluoromethyl)phenyl]sulfonylazepane	[no description available]	low	0	sulfonamide
4-[4-[(5,6-dimethyl-1-benzimidazolyl)sulfonyl]phenyl]sulfonylmorpholine	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-methoxyphenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
4-methyl-N-(pyridin-4-ylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-(benzenesulfonyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-2-[(4-methoxyphenyl)sulfonylamino]benzamide	[no description available]	low	0	sulfonamide
N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide	[no description available]	low	0	sulfonamide
3-[[4-(1-benzotriazolyl)-1-piperidinyl]sulfonyl]-N-cyclopentylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N,N-dimethyl-4-[[4-(5-methyl-1-benzotriazolyl)-1-piperidinyl]sulfonyl]benzamide	[no description available]	low	0	sulfonamide
4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide	[no description available]	low	0	sulfonamide
N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide	[no description available]	low	0	sulfonamide
N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide	[no description available]	low	0	acetamides; piperidines; pyridines; sulfonamide
3,4,5-trimethoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide	[no description available]	low	0	sulfonamide
N-(4-phenylmethoxyphenyl)methanesulfonamide	[no description available]	low	0	sulfonamide
3-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-fluoro-3-methylphenyl)sulfonylamino]acetic acid	[no description available]	low	0	sulfonamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(2-ethylphenoxy)-N-(4-sulfamoylphenyl)acetamide	[no description available]	low	0	sulfonamide
N-(3-chloro-4-hydroxy-2,5-dimethylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-(1-cyclohexenyl)ethyl]-2,5-dimethoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1-ethyl-5-benzimidazolyl)-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
4-methyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-chloro-N-(4-hydrazinyl-6-methyl-2-pyrimidinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-amino-N-(4-ethoxyphenyl)benzenesulfonamide	[no description available]	low	0	benzenes; sulfonamide
1-(2-nitrophenyl)sulfonylpiperidine	[no description available]	low	0	sulfonamide
N,4-dimethyl-N-(4-methylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2,3,4-trimethyl-N-(3-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[4-(1-pyrrolidinylsulfonyl)phenyl]hydrazinylidene]propanedinitrile	[no description available]	low	0	sulfonamide
N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]acetamide	[no description available]	low	0	sulfonamide
4-chloro-3-ethoxy-N-(4-ethylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)sulfonylpyrrolidine	[no description available]	low	0	sulfonamide
1-cyclopropyl-3-(4-sulfamoylphenyl)thiourea	[no description available]	low	0	sulfonamide
N-[3-[methyl(methylsulfonyl)amino]phenyl]-2-phenoxyacetamide	[no description available]	low	0	sulfonamide
4-[methyl(methylsulfonyl)amino]-N-(2-phenylethyl)benzamide	[no description available]	low	0	sulfonamide
2-(2,6-dichloroanilino)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
4-(4-chloroanilino)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
1-ethyl-3-(4-methylphenyl)sulfonylthiourea	[no description available]	low	0	sulfonamide
6-chloro-N-(2-hydroxyphenyl)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
5-chloro-2-methoxy-N,N,4-trimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(2,5-dimethoxyphenyl)sulfonyl-methylamino]acetic acid	[no description available]	low	0	sulfonamide
N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-(1-cyclohexenyl)ethyl]-4-[methyl(methylsulfonyl)amino]benzamide	[no description available]	low	0	sulfonamide
1-(2,5-dimethoxyphenyl)sulfonyl-4-ethylpiperazine	[no description available]	low	0	sulfonamide
N-[2-(methylthio)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-methoxy-5-propan-2-yl-N-(2-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2,3,5,6-tetramethyl-N-(2-methyl-1,3-benzothiazol-5-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-chloro-2-methyl-5-(2-pyridinylsulfamoyl)phenoxy]acetamide	[no description available]	low	0	sulfonamide
N-(3-chlorophenyl)-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-(3-methyl-N-methylsulfonylanilino)acetamide	[no description available]	low	0	sulfonamide
2-[(5-bromo-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide	[no description available]	low	0	sulfonamide
N-[4-[(2,6-dimethoxy-4-pyrimidinyl)sulfamoyl]phenyl]butanamide	[no description available]	low	0	sulfonamide
2-(3-pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole	[no description available]	low	0	sulfonamide
5-bromo-6-chloro-N-(4-methyl-2-pyridinyl)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
4-(4-fluorophenyl)sulfonyl-2-(2-furanyl)-N-phenyl-5-oxazolamine	[no description available]	low	0	sulfonamide
2-[[4-(4-methylphenyl)sulfonyl-1-piperazinyl]methyl]-4-propan-2-ylphenol	[no description available]	low	0	sulfonamide
N-[(2-chlorophenyl)methyl]-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide	[no description available]	low	0	sulfonamide
N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiophen-2-ylacetamide	[no description available]	low	0	sulfonamide
2-[methyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(2-pyridinylmethyl)acetamide	[no description available]	low	0	sulfonamide
2-[(4-ethoxyphenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide	[no description available]	low	0	sulfonamide
1-(4-methylphenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide	[no description available]	low	0	sulfonamide
N-[4-(1-piperidinylsulfonyl)phenyl]-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
N-(1,3-benzothiazol-2-yl)-2-[methyl-(4-methylphenyl)sulfonylamino]acetamide	[no description available]	low	0	sulfonamide
1-cyclohexyl-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea	[no description available]	low	0	sulfonamide
N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide	[no description available]	low	0	sulfonamide
2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-ethoxy-2,3,5-trimethyl-N-(3-pyridinylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
2-[N-(benzenesulfonyl)-4-ethoxyanilino]-N-(2-methoxyphenyl)acetamide	[no description available]	low	0	sulfonamide
4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide	[no description available]	low	0	sulfonamide
5-bromo-2-methoxy-N-(3-methyl-2-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
pyrabactin	[no description available]	low	0	naphthalenes; organobromine compound; pyridines; sulfonamide	abscisic acid receptor agonist; hormone; plant growth regulator
1,4-bis[(4-methoxy-2-methylphenyl)sulfonyl]-1,4-diazepane	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-4-(1-pyrrolidinylsulfonyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-(benzenesulfonyl)-N-methyl-N-phenyl-1-piperazinecarboxamide	[no description available]	low	0	sulfonamide
2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
N-[[1-(benzenesulfonyl)-4-piperidinyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-(1,3-benzodioxol-5-yl)-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea	[no description available]	low	0	sulfonamide
1-(1,3-benzodioxol-5-yl)-3-[4-[(phenylmethyl)sulfamoyl]phenyl]urea	[no description available]	low	0	sulfonamide
1,3-diethyl-6-methyl-N-(2-methylphenyl)-2-oxo-5-benzimidazolesulfonamide	[no description available]	low	0	sulfonamide
N-(1,3-benzodioxol-5-ylmethyl)-4-methyl-3-(1-piperidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide	[no description available]	low	0	sulfonamide
1-methylsulfonyl-N-(6,7,8,9-tetrahydrodibenzofuran-2-yl)-2,3-dihydroindole-5-sulfonamide	[no description available]	low	0	sulfonamide
2-[2-chloro-4-(2,3-dihydroindol-1-ylsulfonyl)phenoxy]-N-(2-pyridinylmethyl)acetamide	[no description available]	low	0	sulfonamide
1-(4-bromo-3-ethoxyphenyl)sulfonyl-3,5-dimethylpyrazole	[no description available]	low	0	sulfonamide
N-(4-hydroxy-3,5-dimethylphenyl)-2,5-dimethyl-3-thiophenesulfonamide	[no description available]	low	0	sulfonamide
5-[(5-tert-butyl-2,3-dimethylphenyl)sulfonylamino]-2-hydroxybenzoic acid	[no description available]	low	0	sulfonamide
1-(4-chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole	[no description available]	low	0	sulfonamide
2-[4-chloro-5-(cyclopentylsulfamoyl)-2-methylphenoxy]-N-cyclohexylacetamide	[no description available]	low	0	sulfonamide
2-(1,3-benzothiazol-2-ylthio)-N-(4-methylphenyl)sulfonylacetamide	[no description available]	low	0	sulfonamide
2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
2-[1-(4-tert-butylphenyl)sulfonyl-4-piperidinyl]-6-chloro-1H-benzimidazole	[no description available]	low	0	sulfonamide
2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-[4-(1-pyrrolidinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
4-[[3-[(2-chlorophenyl)methyl]-5-cyclopropyl-7-triazolo[4,5-d]pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
7-methyl-2-[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]-3-quinolinecarbonitrile	[no description available]	low	0	sulfonamide
6-amino-5-(benzenesulfonyl)-2-methoxy-3-pyridinecarbonitrile	[no description available]	low	0	sulfonamide
6-amino-5-(4-chlorophenyl)sulfonyl-2-oxo-1H-pyridine-3-carbonitrile	[no description available]	low	0	sulfonamide
2-[benzenesulfonyl(2-pyridinyl)amino]acetic acid	[no description available]	low	0	sulfonamide
2-[(4-chlorophenyl)sulfonyl-(2-pyridinyl)amino]acetic acid	[no description available]	low	0	sulfonamide
2,5-dichloro-N-(1,5,6-trimethyl-4-benzimidazolyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide	[no description available]	low	0	sulfonamide
5-[1-(benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole	[no description available]	low	0	sulfonamide
5-[1-(4-fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole	[no description available]	low	0	sulfonamide
N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(benzenesulfonylmethyl)-5-(4-chlorophenyl)cyclohexane-1,3-dione	[no description available]	low	0	sulfonamide
1-(benzenesulfonyl)-3-pyrazolidinone	[no description available]	low	0	sulfonamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methyl-4-pyrazolesulfonamide	[no description available]	low	0	sulfonamide
N-(4-methoxyphenyl)-2-(3-methylphenoxy)-N-(4-methylphenyl)sulfonylacetamide	[no description available]	low	0	sulfonamide
N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[[4-(diethylsulfamoyl)phenyl]-oxomethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
tosylarginine methyl ester	[no description available]	low	0	guanidines; L-arginine ester; methyl ester; sulfonamide
n-(4-(n-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide	[no description available]	low	0	pyrazines; sulfonamide; thiophenes	necroptosis inhibitor; neuroprotective agent
N-[(benzenesulfonylhydrazo)-sulfanylidenemethyl]-4-methylbenzamide	[no description available]	low	0	sulfonamide
xl147	[no description available]	low	0	aromatic amine; benzothiadiazole; quinoxaline derivative; sulfonamide	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
7-chloro-2-methyl-4-(4-methylphenyl)sulfonylthiazolo[5,4-b]indole	[no description available]	low	0	sulfonamide
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(4-methyl-1-piperidinyl)sulfonyl]benzamide	[no description available]	low	0	sulfonamide
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
4-(4-bromophenyl)sulfonyl-2-(2-furanyl)-5-(methylthio)oxazole	[no description available]	low	0	sulfonamide
4-(4-morpholinylsulfonyl)-N-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone	[no description available]	low	0	sulfonamide
4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
N-(1,3-benzothiazol-2-yl)-3-(2,3-dihydroindol-1-ylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
1-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio]ethanone	[no description available]	low	0	sulfonamide
3-[4-(4-morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]ethanone	[no description available]	low	0	sulfonamide
2,5-difluoro-N-[2-(4-morpholinylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
N-(2-methyl-1,3-benzothiazol-6-yl)-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
3-[(4-acetyl-1-piperazinyl)sulfonyl]-N-(1H-benzimidazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
3-[(3-hydroxy-5-benzotriazolyl)sulfonylamino]benzoic acid	[no description available]	low	0	sulfonamide
3-[(5-chloro-2,4-dimethoxyphenyl)-methylsulfamoyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
2-(2-fluorophenoxy)-N-[4-(2-furanylmethylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
3-[[[5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1,2,3-benzotriazin-4-one	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-yl)-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
2,6-dichloro-N-[2-(methylthio)-1,3-benzothiazol-6-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
4-fluoro-3-methoxy-N-(2-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-(5-ethyl-1,3,4-oxadiazol-2-yl)-4-[methyl(phenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
4-[bis(2-methoxyethyl)sulfamoyl]-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
4-[butyl(methyl)sulfamoyl]-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
4-[ethyl-(phenylmethyl)sulfamoyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
4-[ethyl-(phenylmethyl)sulfamoyl]-N-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
4-[bis(2-methylpropyl)sulfamoyl]-N-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-methyl-2-thiazolyl)thio]ethanone	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone	[no description available]	low	0	sulfonamide
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-nitrobenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(5-butyl-1H-1,2,4-triazol-3-yl)thio]-N-(4-sulfamoylphenyl)acetamide	[no description available]	low	0	sulfonamide
2-ethoxy-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
N-[4-(dibutylsulfamoyl)phenyl]-2-thiophen-2-ylacetamide	[no description available]	low	0	sulfonamide
2,3-dichloro-4-methoxy-N-(3-methoxypropyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(3-cyano-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-2-yl)thio]-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-2-[4-(propylsulfamoyl)phenoxy]acetamide	[no description available]	low	0	sulfonamide
4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
4-methyl-N-[2-(phenylmethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-chloro-5-(cyclohexylsulfamoyl)-2-methylphenoxy]-N-(1,3,4-thiadiazol-2-yl)acetamide	[no description available]	low	0	sulfonamide
N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea	[no description available]	low	0	sulfonamide
N-[4-(cyanomethyl)phenyl]-4-cyclohexylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(4-ethoxyphenyl)-4-[[4-(methylthio)phenyl]sulfonylamino]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(methanesulfonamido)-N-[2-(phenylmethylthio)ethyl]benzamide	[no description available]	low	0	sulfonamide
N-(2-fluorophenyl)-4-methoxy-2,5-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[benzenesulfonyl-(phenylmethyl)amino]-N-ethylacetamide	[no description available]	low	0	sulfonamide
4-[benzenesulfonyl(methyl)amino]-N-[2-[(4-chlorophenyl)methylthio]ethyl]benzamide	[no description available]	low	0	sulfonamide
N-(3,4-dimethyl-2-sulfanylidene-5-thiazolyl)carbamic acid 2-[(2,5-dimethylphenyl)sulfonylamino]ethyl ester	[no description available]	low	0	sulfonamide
2-[cyclohexyl-(4-methylphenyl)sulfonylamino]-N-(3-methoxypropyl)acetamide	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-yl)-4-(dimethylsulfamoyl)benzamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)-3-[2-(thiophen-2-ylsulfonylamino)phenyl]urea	[no description available]	low	0	sulfonamide
2-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-ylmethyl)-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-fluoro-2-methylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-cyanophenyl)methylthio]-N-(2-methoxyphenyl)-1,3-benzoxazole-5-sulfonamide	[no description available]	low	0	sulfonamide
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
3-(1-azepanylsulfonyl)-4-chloro-N-(1H-1,2,4-triazol-5-yl)benzamide	[no description available]	low	0	sulfonamide
sr 3335	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-ylmethyl)-4-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-chlorophenyl)methylthio]-5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazole	[no description available]	low	0	sulfonamide
4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide	[no description available]	low	0	sulfonamide
1-(2-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester	[no description available]	low	0	sulfonamide
3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide	[no description available]	low	0	sulfonamide
2-[5-(1-pyrrolidinylsulfonyl)-2-thiophenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide	[no description available]	low	0	sulfonamide
1-(4-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester	[no description available]	low	0	sulfonamide
3-(2-chlorophenyl)sulfonylpropanoic acid [2-[(3,5-dichloro-6-methyl-2-pyridinyl)amino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
2-[4-[benzenesulfonyl(methyl)amino]phenoxy]-N-(1,3-benzothiazol-2-yl)acetamide	[no description available]	low	0	sulfonamide
N-(6-methoxy-1,3-benzothiazol-2-yl)-3-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
N-cyclopentyl-3,4-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
6-amino-1-(2-methoxyethyl)-N-(4-methylphenyl)sulfonyl-2,4-dioxo-5-pyrimidinecarboxamide	[no description available]	low	0	sulfonamide
3-(benzenesulfonyl)propanoic acid [2-[(3,5-dichloro-4-methyl-2-pyridinyl)amino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
[4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone	[no description available]	low	0	sulfonamide
[4-(4-bromo-2-chlorophenyl)sulfonyl-1-piperazinyl]-(2-sulfanylidene-1H-pyridin-3-yl)methanone	[no description available]	low	0	sulfonamide
[1-(4-fluorophenyl)sulfonyl-4-piperidinyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone	[no description available]	low	0	sulfonamide
N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
1-[4-(3-chloro-2,4,6-trifluorophenyl)sulfonyl-1-piperazinyl]ethanone	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone	[no description available]	low	0	sulfonamide
2-(4-methoxyphenyl)-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
N1-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide	[no description available]	low	0	sulfonamide
2-(benzenesulfonylmethyl)-5-(4-methoxyphenyl)cyclohexane-1,3-dione	[no description available]	low	0	sulfonamide
2-[bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester	[no description available]	low	0	sulfonamide
N1-{3-[2-(2-pyridyl)ethyl]phenyl}-4-chlorobenzene-1-sulfonamide	[no description available]	low	0	sulfonamide
ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate	[no description available]	low	0	ethyl ester; monochlorobenzenes; organofluorine compound; pyrazoles; sulfonamide
2,3-dichloro-N'-[4-(trifluoromethyl)-2-pyrimidinyl]benzenesulfonohydrazide	[no description available]	low	0	sulfonamide
1-(4-ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea	[no description available]	low	0	sulfonamide
1-(3,5-dimethylphenyl)-3-[5-(dimethylsulfamoyl)-2-methylphenyl]urea	[no description available]	low	0	sulfonamide
N-{5-[(dimethylamino)sulfonyl]-2-methylphenyl}cyclohexanecarboxamide	[no description available]	low	0	sulfonamide
1-tert-butyl-3-[(4-methylphenyl)sulfonylamino]thiourea	[no description available]	low	0	sulfonamide
3-methyl-4,7-bis(methylsulfonyl)-3a,5,6,7a-tetrahydro-1H-imidazo[4,5-b]pyrazin-2-one	[no description available]	low	0	imidazopyrazine; sulfonamide; ureas
N-(3-acetyl-2-methyl-5-benzofuranyl)-N-(4-chloro-3-nitrophenyl)sulfonylacetamide	[no description available]	low	0	sulfonamide
2-[(4-chlorophenyl)thio]-N-[4-[(2,4-dimethylphenyl)sulfamoyl]phenyl]propanamide	[no description available]	low	0	sulfonamide
4-chloro-N-[2-(4-morpholinyl)cyclohexyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[3-(2-furanyl)-3-phenylpropyl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[4-(butylsulfamoyl)phenyl]-2-phenyl-2-(phenylthio)acetamide	[no description available]	low	0	sulfonamide
N-[2,6-dimethyl-3-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N,4-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid	[no description available]	low	0	sulfonamide
N-[4-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiazolyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide	[no description available]	low	0	sulfonamide
4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-[oxo-[1-(2,4,6-trimethylphenyl)sulfonyl-4-piperidinyl]methyl]-1-piperazinecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
N,4-dimethyl-N-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-(1-phenylethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]methanesulfonamide	[no description available]	low	0	sulfonamide
N-[1-(4-chlorophenyl)sulfonyl-2-pyrrolidinyl]-4-methyl-1-piperazinecarboxamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[1-(2-methylpropyl)-2-benzimidazolyl]thio]ethanone	[no description available]	low	0	sulfonamide
N-[4-[(4-hydroxyphenyl)-methylsulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
6-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-N-ethyl-N-phenyl-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
4-chloro-N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2,3-dihydro-1,4-benzodioxin-3-yl-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]methanone	[no description available]	low	0	sulfonamide
N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
1-(benzenesulfonyl)-2-benzimidazolamine	[no description available]	low	0	sulfonamide
1-(4-nitrophenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
sulfatolamide	[no description available]	low	0	benzenes; sulfonamide
e 7010	[no description available]	low	0	sulfonamide
deracoxib	[no description available]	low	0	organofluorine compound; pyrazoles; sulfonamide	cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
diclosulam	[no description available]	low	0	sulfonamide
N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
3-nitro-N-(pyridin-4-ylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[2-[(4-acetamidophenyl)sulfonylamino]-4-thiazolyl]acetic acid ethyl ester	[no description available]	low	0	sulfonamide
1-[3-(benzenesulfonyl)-2-(1-piperidinyl)propyl]piperidine	[no description available]	low	0	sulfonamide
6-(2-furanyl)-4-[4-(methanesulfonamido)phenyl]-2-oxo-1-cyclohex-3-enecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide	[no description available]	low	0	sulfonamide
1-(2-furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea	[no description available]	low	0	sulfonamide
N1-butan-2-yl-N4-[2-(3,4-dimethoxyphenyl)ethyl]-N4-(thiophen-2-ylmethyl)benzene-1,4-disulfonamide	[no description available]	low	0	sulfonamide
1-(4-chlorophenyl)sulfonyl-N'-[oxo-[4-(1-piperidinylsulfonyl)phenyl]methyl]-4-piperidinecarbohydrazide	[no description available]	low	0	sulfonamide
N,N-dimethyl-4-[[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]sulfonyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-(4-methylphenyl)sulfonyl-3-methylsulfonylimidazolidine	[no description available]	low	0	sulfonamide
1-(4-bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane	[no description available]	low	0	sulfonamide
2-[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
1-(4-chlorophenyl)sulfonyl-N-(2-thiazolyl)-1-cyclopropanecarboxamide	[no description available]	low	0	sulfonamide
1-methyl-N-[4-(trifluoromethyl)phenyl]-4-imidazolesulfonamide	[no description available]	low	0	sulfonamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methylanilino]acetamide	[no description available]	low	0	sulfonamide
N,N-diethyl-4-[[5-oxo-6-(phenylmethyl)-7H-pyrrolo[3,4-b]pyridin-7-yl]amino]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1,3-benzodioxol-5-yl)-5-bromo-1-[cyclopropyl(oxo)methyl]-N-ethyl-2,3-dihydroindole-7-sulfonamide	[no description available]	low	0	sulfonamide
N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide	[no description available]	low	0	sulfonamide
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-methylanilino]acetamide	[no description available]	low	0	sulfonamide
cyclopentanecarboxylic acid [4-(benzenesulfonyl)-2-tert-butyl-5-methyl-3-pyrazolyl] ester	[no description available]	low	0	sulfonamide
4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide	[no description available]	low	0	sulfonamide
4-methyl-N-[2,4,6-trioxo-1-phenyl-5-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
6-ethyl-2-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
4-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamide	[no description available]	low	0	benzenes; sulfonamide
4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide	[no description available]	low	0	sulfonamide
2-[(5-chloro-1,3-benzothiazol-2-yl)thio]-N-[3-(4-morpholinylsulfonyl)phenyl]propanamide	[no description available]	low	0	sulfonamide
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methoxy-3-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2-ethoxy-3-pyridinecarboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
N-[4-[2-(2-ethyl-1-oxobutyl)-3-phenyl-3,4-dihydropyrazol-5-yl]phenyl]methanesulfonamide	[no description available]	low	0	sulfonamide
N-[3-[(2-chlorophenyl)sulfamoyl]-4-methoxyphenyl]-4-oxo-4-thiophen-2-ylbutanamide	[no description available]	low	0	sulfonamide
2-(4-methyl-N-(4-methylphenyl)sulfonylanilino)-N-[(1-methyl-4-piperidinylidene)amino]acetamide	[no description available]	low	0	sulfonamide
fh535	[no description available]	low	0	sulfonamide
1-[4-chloro-3-[(2-methoxyphenyl)sulfamoyl]phenyl]-3-(2-methoxyphenyl)urea	[no description available]	low	0	sulfonamide
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide	[no description available]	low	0	sulfonamide
2-[[[5-(dimethylsulfamoyl)-2-methylanilino]-sulfanylidenemethyl]hydrazo]-2-oxoacetamide	[no description available]	low	0	sulfonamide
1-(4-butylphenyl)-3-[4-chloro-3-(dimethylsulfamoyl)phenyl]thiourea	[no description available]	low	0	sulfonamide
6-methyl-2-[[oxo-[4-(1-pyrrolidinylsulfonyl)phenyl]methyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
2-(1,3-benzothiazol-2-ylthio)-N-[2-hydroxy-5-(4-morpholinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
1-butyl-4,6-dimethyl-3-(2-methylphenyl)sulfonyl-2-pyridinone	[no description available]	low	0	sulfonamide
4-(4-methylphenyl)sulfonyl-3-phenyl-2,3-dihydro-1,4-benzoxazine	[no description available]	low	0	sulfonamide
N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide	[no description available]	low	0	1,4-naphthoquinones; piperazines; sulfonamide
N-(2,2,4-trimethyl-3H-benzofuran-7-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-furanyl-[4-(4-propan-2-ylphenyl)sulfonyl-1-piperazinyl]methanone	[no description available]	low	0	sulfonamide
5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide	[no description available]	low	0	benzenes; sulfonamide
N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(diethylsulfamoyl)-2-methoxyphenyl]-2-[(2,5-dimethylphenyl)thio]acetamide	[no description available]	low	0	sulfonamide
2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-[3-(1-imidazolyl)propyl]benzamide	[no description available]	low	0	sulfonamide
2-[[3-(3-oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acid	[no description available]	low	0	sulfonamide
N-[(1,2-dimethyl-5-indolyl)methyl]-4-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N,6-dimethyl-2-[[[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
N-cyclopropyl-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[1-(1H-benzimidazol-2-yl)ethyl]-3-(dimethylsulfamoyl)benzamide	[no description available]	low	0	sulfonamide
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(3-methyl-1-piperidinyl)sulfonyl]benzamide	[no description available]	low	0	sulfonamide
N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
2,3-dihydro-1,4-benzodioxin-3-carboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
2-(1,3-benzothiazol-2-ylthio)-N-[2-chloro-5-(4-morpholinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
1-[3-(dimethylsulfamoyl)phenyl]-3-(2-furanylmethyl)thiourea	[no description available]	low	0	sulfonamide
5-nitro-2-furancarboxylic acid [2-oxo-2-[3-(1-piperidinylsulfonyl)anilino]ethyl] ester	[no description available]	low	0	sulfonamide
N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline	[no description available]	low	0	benzenes; sulfonamide
N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide	[no description available]	low	0	sulfonamide
N-[3-[2-(4-fluorophenyl)sulfonyl-3-thiophen-2-yl-3,4-dihydropyrazol-5-yl]phenyl]ethanesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-[(2-methyl-1-piperidinyl)sulfonyl]benzamide	[no description available]	low	0	sulfonamide
N-[(3,5-dimethyl-1-piperidinyl)-sulfanylidenemethyl]-2-methyl-5-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
4-[bis(2-methoxyethyl)sulfamoyl]-N-[5-(methoxymethyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
2-(benzenesulfonamido)-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid propan-2-yl ester	[no description available]	low	0	isopropyl ester; sulfonamide
2-(3,4-dichlorophenyl)-N-[3-(dimethylsulfamoyl)-4-methylphenyl]acetamide	[no description available]	low	0	sulfonamide
N-Cyclopentyl-2-(N-methyl3-chlorobenzenesulfonamido)acetamide	[no description available]	low	0	sulfonamide	anticoronaviral agent
N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide	[no description available]	low	0	sulfonamide
1-(4-methoxyphenyl)-3-[3-(1-piperidinylsulfonyl)phenyl]thiourea	[no description available]	low	0	sulfonamide
1-[2-(trifluoromethyl)phenyl]sulfonyl-4-piperidinecarboxylic acid [2-[(4-fluorophenyl)methylamino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid [2-[4-methyl-3-(1-piperidinylsulfonyl)anilino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
3-[4-(4-butan-2-ylphenyl)sulfonyl-1-piperazinyl]butanoic acid	[no description available]	low	0	sulfonamide
3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
2-[[4-(2-methoxyphenyl)sulfonyl-1-piperazinyl]sulfonyl]benzonitrile	[no description available]	low	0	sulfonamide
2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)-N-prop-2-enylbenzamide	[no description available]	low	0	sulfonamide
1-(7-methyloctyl)-3-[4-(4-morpholinylsulfonyl)phenyl]thiourea	[no description available]	low	0	sulfonamide
5-[(5-bromo-2-ethoxyphenyl)sulfonylamino]-2-chloro-N,N-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-(3-sulfamoylphenyl)acetamide	[no description available]	low	0	sulfonamide
N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
4-(dimethylsulfamoyl)-N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
N-methyl-2-[[[4-[methyl(phenyl)sulfamoyl]phenyl]-oxomethyl]amino]-6-propyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
1-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-3-phenylurea	[no description available]	low	0	sulfonamide
3-(4-methylphenyl)sulfonyl-3-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid	[no description available]	low	0	sulfonamide
N-(3,4-difluorophenyl)-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-ethoxyanilino]acetamide	[no description available]	low	0	sulfonamide
5-[(4-methoxyphenyl)sulfonylmethyl]-N-(3-methoxypropyl)-2-furancarboxamide	[no description available]	low	0	sulfonamide
N-cyclohexyl-N-ethyl-1,3-dimethyl-2,4-dioxo-5-pyrimidinesulfonamide	[no description available]	low	0	pyrimidone; sulfonamide
1,3-dimethyl-2,4-dioxo-N-(4-propan-2-ylphenyl)-5-pyrimidinesulfonamide	[no description available]	low	0	sulfonamide
2,5-dimethoxy-N-[[2-(4-methoxyphenyl)-4-thiazolyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
kn 93	[no description available]	low	0	monochlorobenzenes; monomethoxybenzene; primary alcohol; sulfonamide; tertiary amino compound	EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor; geroprotector
ro 4-6790	[no description available]	low	0	benzenes; sulfonamide
jnj-7706621	[no description available]	low	0	sulfonamide
sultan	[no description available]	low	0	sulfonamide
1-[2-furanyl(oxo)methyl]-N-[4-[(3-methyl-1-piperidinyl)sulfonyl]phenyl]-4-piperidinecarboxamide	[no description available]	low	0	sulfonamide
sb 269970	[no description available]	low	0	sulfonamide
belinostat	[no description available]	low	0	hydroxamic acid; olefinic compound; sulfonamide	antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor
2-bromo-N-(phenylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine	[no description available]	low	0	sulfonamide
((3z)-n-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1h-pyrrol-2-yl)methylene)-n-methyl-2-oxo-2,3-dihydro-1h-indole-5-sulfonamide)	[no description available]	low	0	sulfonamide
N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
5-chloro-N-[4-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
4-methyl-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide	[no description available]	low	0	organofluorine compound; pyrazoles; sulfonamide	cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
bm 567	[no description available]	low	0	benzenes; sulfonamide
mre 269	[no description available]	low	0	aromatic amine; ether; monocarboxylic acid; pyrazines; sulfonamide; tertiary amino compound	drug metabolite; orphan drug; platelet aggregation inhibitor; prostacyclin receptor agonist; vasodilator agent
pazopanib	[no description available]	low	0	aminopyrimidine; indazoles; sulfonamide	angiogenesis modulating agent; antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist
azd2858	[no description available]	low	0	aromatic amine; N-methylpiperazine; pyrazines; pyridines; secondary carboxamide; sulfonamide	antineoplastic agent; bone density conservation agent; EC 2.7.11.26 (tau-protein kinase) inhibitor; Wnt signalling activator
4-(2-((1r)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid	[no description available]	low	0	sulfonamide
apratastat	[no description available]	low	0	sulfonamide
N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide	[no description available]	low	0	sulfonamide
florasulam	[no description available]	low	0	sulfonamide
(1S,2R)-2-[[4-[(2,4-dimethylphenyl)sulfamoyl]anilino]-oxomethyl]-1-cyclohexanecarboxylic acid	[no description available]	low	0	sulfonamide
3-[1-(4-bromophenyl)sulfonyl-3,6-dihydro-2H-pyridin-4-yl]-1,2-dimethylindole	[no description available]	low	0	sulfonamide
4-[3-(3-fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]amino]-3-thiophenecarboxamide	[no description available]	low	0	sulfonamide
4-[3-(4-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-[ethyl(phenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide	[no description available]	low	0	sulfonamide
calcium crimson	[no description available]	low	0	ammonium betaine; sulfonamide	fluorochrome
4-methoxy-N-[[1-[(3-methyl-2-thiophenyl)-oxomethyl]-3-piperidinyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N'-[[3-(4-methylphenyl)sulfonyl-2-oxazolidinyl]methyl]-N-[2-(4-sulfamoylphenyl)ethyl]oxamide	[no description available]	low	0	sulfonamide
tg101209	[no description available]	low	0	N-alkylpiperazine; N-arylpiperazine; pyrimidines; secondary amino compound; sulfonamide	antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
fedratinib	[no description available]	low	0	sulfonamide
WAY-316606	[no description available]	low	0	(trifluoromethyl)benzenes; piperidines; secondary amino compound; sulfonamide; sulfone	secreted frizzled-related protein 1 inhibitor
azd5438	[no description available]	low	0	sulfonamide
gdc 0941	[no description available]	low	0	indazoles; morpholines; piperazines; sulfonamide; thienopyrimidine	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
4-methoxy-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-[methyl-(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide	[no description available]	low	0	sulfonamide
gsk 1016790a	[no description available]	low	0	1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide	TRPV4 agonist
plx 4720	[no description available]	low	0	aromatic ketone; difluorobenzene; organochlorine compound; pyrrolopyridine; sulfonamide	antineoplastic agent; B-Raf inhibitor
gsk 2126458	[no description available]	low	0	aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide	anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-fluorophenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
(2R)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
[4-(2,6-difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone	[no description available]	low	0	sulfonamide
(2R)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
(2S)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
(2S)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-pyridinylsulfonyl)piperazine	[no description available]	low	0	pyridines; sulfonamide
N-[1-(2,6-difluorophenyl)sulfonyl-4-piperidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepane	[no description available]	low	0	sulfonamide
N-[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[3-(trifluoromethyl)phenyl]sulfonylpiperazine	[no description available]	low	0	sulfonamide
N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[3-[(2,6-difluorophenyl)sulfonylamino]propyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[5-[(2,6-difluorophenyl)sulfonylamino]pentyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[6-[(2,6-difluorophenyl)sulfonylamino]hexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[2-[(2,6-difluorophenyl)sulfonylamino]ethyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[4-[(2,6-difluorophenyl)sulfonylamino]butyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-nitrophenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
4-[4-(4-methylphenyl)sulfonyl-1-piperazinyl]-2-thiophen-2-ylquinazoline	[no description available]	low	0	sulfonamide
plx4032	[no description available]	low	0	aromatic ketone; difluorobenzene; monochlorobenzenes; pyrrolopyridine; sulfonamide	antineoplastic agent; B-Raf inhibitor
N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	[no description available]	low	0	sulfonamide
1-(3-bromophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	[no description available]	low	0	sulfonamide
(1S,4S)-2-(2,6-difluorophenyl)sulfonyl-5-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2,5-diazabicyclo[2.2.1]heptane	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2,4,6-trifluorophenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
N-(1-cyano-3-pyrrolidinyl)-3-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1-cyano-4-piperidinyl)-4-(trifluoromethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-[3-(3-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
4-[3-(3-bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-cyclohexyl-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide	[no description available]	low	0	sulfonamide
N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide	[no description available]	low	0	sulfonamide
3-cyclohexyl-1-[[(2S,3S)-8-[(4-fluorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea	[no description available]	low	0	sulfonamide
3-cyclohexyl-1-[[(2R,3R)-10-[(4-fluorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea	[no description available]	low	0	sulfonamide
4-chloro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide	[no description available]	low	0	sulfonamide
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide	[no description available]	low	0	sulfonamide
1-[(2R,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea	[no description available]	low	0	sulfonamide
baricitinib	[no description available]	low	0	azetidines; nitrile; pyrazoles; pyrrolopyrimidine; sulfonamide	anti-inflammatory agent; antirheumatic drug; antiviral agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; immunosuppressive agent
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
sr1001	[no description available]	low	0	sulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
dabrafenib	[no description available]	low	0	1,3-thiazoles; aminopyrimidine; organofluorine compound; sulfonamide	anticoronaviral agent; antineoplastic agent; B-Raf inhibitor
3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]aniline	[no description available]	low	0	benzenes; sulfonamide
4-[[(4-ethylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide	[no description available]	low	0	sulfonamide
EG00229	[no description available]	low	0	benzothiadiazole; dicarboxylic acid monoamide; L-arginine derivative; secondary carboxamide; sulfonamide; thiophenes	angiogenesis inhibitor; antineoplastic agent; neuropilin receptor antagonist
gsk0660	[no description available]	low	0	sulfonamide
xl765	[no description available]	low	0	aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor
N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)-oxomethyl]-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide	[no description available]	low	0	sulfonamide
tipranavir	[no description available]	low	0	sulfonamide	antiviral drug; HIV protease inhibitor
abt-333	[no description available]	low	0	aromatic ether; naphthalenes; pyrimidone; sulfonamide	antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor
pik 75	[no description available]	low	0	sulfonamide
vx-970	[no description available]	low	0	sulfonamide
pf-543	[no description available]	low	0	sulfonamide
ML355	[no description available]	low	0	benzothiazoles; monomethoxybenzene; phenols; secondary amino compound; substituted aniline; sulfonamide	EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; platelet aggregation inhibitor
sr9243	[no description available]	low	0	bromobenzenes; sulfonamide; sulfone	antineoplastic agent; apoptosis inducer; liver X receptor inverse agonist
da 8159	[no description available]	low	0	sulfonamide
3-[[2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-oxoethyl]thio]-6-methyl-2H-1,2,4-triazin-5-one	[no description available]	low	0	sulfonamide
N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[4-[2-[3-(dimethylsulfamoyl)anilino]-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide	[no description available]	low	0	sulfonamide
N-[2-[(4-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-[(2-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(4-methoxyphenyl)-2-[[6-[(4-methylphenyl)sulfonylamino]-4-oxo-1H-pyrimidin-2-yl]thio]acetamide	[no description available]	low	0	sulfonamide
mirodenafil	[no description available]	low	0	aromatic ether; N-alkylpiperazine; primary alcohol; pyrrolopyrimidine; sulfonamide	EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent
da-8164	[no description available]	low	0	sulfonamide

carzenide

Cross-References

Synonyms (123)

Drug Classes (1)

Protein Targets (42)

Potency Measurements

Inhibition Measurements

Activation Measurements

Other Measurements

Biological Processes (29)

Molecular Functions (15)

Ceullar Components (22)

Bioassays (248)

Research

Studies (87)

Study Types

Research Highlights

Bioavailability (2)

Dosage (1)

Condition	Relationship Strength	Studies
American Trypanosomiasis	low	1
Anemia, Fanconi	low	1
Benign Neoplasms	low	1
Brucella Infection	low	1
Brucellosis	low	1
Brucellosis, Pulmonary	low	1
Cancer	low	1
Cancer of Stomach	low	2
Cancer of the Stomach	low	2
Chagas Disease	low	1
Chagas' Disease	low	1
Cholera	low	1
Congenital Zika Syndrome	low	1
Congenital Zika Virus Infection	low	1
Cronobacter Infections	low	1
Cyprus Fever	low	1
Dermatomycoses	low	1
Dermatomycosis	low	1
Dermatophyte Infection	low	1
Disease Models, Animal	low	1
Enterobacteriaceae Infections	low	1
Enterobacterial Infections	low	1
Fanconi Anemia	low	1
Fanconi Hypoplastic Anemia	low	1
Fanconi Pancytopenia	low	1
Fanconi Panmyelopathy	low	1
Fanconi's Anemia	low	1
Fever, Zika	low	1
Fungal Skin Diseases	low	1
Gastric Cancer	low	2
Gastric Cancer, Familial Diffuse	low	2
Gastric Neoplasms	low	2
Gastric Ulcer	low	2
Gastritis	low	1
Gibraltar Fever	low	1
Glaucoma	low	1
Infections, Enterobacteriaceae	low	1
Infections, Enterobacterial	low	1
Infections, Salmonella	low	1
Inflammation	low	1
Innate Inflammatory Response	low	1
Leishmania Infection	low	1
Leishmaniasis	low	1
Malaria, Falciparum	low	1
Malignancy	low	1
Malignant Neoplasms	low	1
Malta Fever	low	1
Neoplasia	low	1
Neoplasm	low	1
Neoplasms	low	1
Neoplasms, Benign	low	1
Neoplasms, Gastric	low	2
Neoplasms, Stomach	low	2
Plasmodium falciparum Malaria	low	1
Rock Fever	low	1
Salmonella Infections	low	1
Salmonellosis	low	1
Scalp Dermatoses	low	1
Scalp Dermatosis	low	1
Skin Diseases, Fungal	low	1
Stomach Cancer	low	2
Stomach Neoplasms	low	2
Stomach Ulcer	low	2
Trypanosoma cruzi Infection	low	1
Trypanosomiasis, South American	low	1
Tumors	low	1
Undulant Fever	low	1
Vibrio cholerae Infection	low	1
Zika Fever	low	1
Zika Virus Disease	low	1
Zika Virus Infection	low	1
ZikV Infection	low	1

Article	Year
Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design. Journal of medicinal chemistry, Dec-05, Volume: 40, Issue: 25	1997
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

carzenide

Cross-References

Synonyms (123)

Drug Classes (1)

Protein Targets (42)

Potency Measurements

Inhibition Measurements

Activation Measurements

Other Measurements

Biological Processes (29)

Molecular Functions (15)

Ceullar Components (22)

Bioassays (248)

Research

Studies (87)

Study Types

Related Drugs (1,446)

Related Conditions (72)

Research Highlights

Bioavailability (2)

Dosage (1)